Trading Analysis Report: INTU¶

Analysis date: 2026-10-21
Rating: Hold
Generated: 2026-10-21 12:25:06
TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports¶

Market Analyst¶

Current Price: 334.52 Price As Of: 2026-10-21

INTU (Intuit Inc., NMS): Technical Report¶

1. Data integrity notes¶

Sources agree. The verified snapshot matches the price CSV and the indicator tool outputs. The close is 334.52, RSI is 64.91, ATR is 12.10 and MACD histogram is 6.21 in both. I found no discrepancies.
The latest bar is probably incomplete. The 2026-10-21 volume is 951,640 shares. Recent sessions ran about 2.5M to 4.5M. The 334.52 close could still change, and so could every indicator that depends on it. Treat it as provisional until the session closes. This is my inference from the volume. The tools don't label the bar as partial.
Indicator choices. I used 8 indicators: supertrend, adx, rsi, macdh, atr, obv, td_9 and z_score. The snapshot already supplied the 10 EMA, 50 SMA, 200 SMA, Bollinger bands and MACD values. I did not pull +DI/-DI, so I infer ADX direction from price.

2. Big picture: a deep downtrend with a sharp counter-trend rally¶

The year-long decline: The close fell from 665.66 on 2025-10-21 to 334.52 now, about -49.7%. The closing high in the window was 673.89 on 2025-10-27. The closing low was 252.77 on 2026-06-25, which is about -62.5% from that high. The intraday low was 250.56 on 2026-06-22.
Heavy-volume breaks:
2026-01-14: close of 559.75 on 4.83M shares.
2026-02-03: close of 428.84 on 7.57M shares.
2026-05-21: the close fell from 380.46 to 304.30 (about -20.0%) on 22.35M shares, roughly 6 to 7 times typical volume.
The tools don't say what caused these moves, so check the event calendar.
Since late June: Closes have mostly ranged between 252.77 and 368.20 (2026-08-24). The recent high of 337.58 on 2026-09-14 is a lower high than August's. The September low of 266.79 on 2026-09-29 is a higher low than June's.
The current bounce: The close rose from 266.79 on 2026-09-29 to 334.52, about +25.4% in 16 sessions. RSI went from 27.38 to 64.91 over the same stretch.

3. Trend structure (weekly outranks monthly, which outranks daily)¶

Timeframe	SuperTrend	Stop	Close vs. stop
Weekly (Tier 1)	DOWN	390.56	-14.35%
Monthly (Tier 2)	DOWN	561.87	-40.46%
Daily (Tier 3)	UP	298.38	+12.11%

The higher tiers are bearish. The weekly and monthly trends are both down, so the primary regime is still bearish. The daily UP signal is a counter-trend bounce inside it.
What would change the weekly regime. A weekly close above 390.56 would be needed. That is about 16.8% above the current price, and it sits above the August high of 371.25 and the 200 SMA.
Moving averages:

Average	Value	Price vs. average
10 EMA	319.04	Above
50 SMA	319.80	Above
200 SMA	367.51	About 9.9% below

The 10 EMA and 50 SMA sit within a point of each other, forming a support cluster near 319 to 320. The 50 SMA is still below the 200 SMA, so the long-term structure remains bearish.

4. Momentum: strong, but plateauing¶

MACD: The line is 6.10 against a signal of -0.11, for a histogram of 6.21. The histogram turned positive on 2026-10-06 (0.18) and climbed to a peak of 6.41 on 2026-10-20. It ticked down to 6.21 on 2026-10-21. That is a flattening, not yet a rollover, and the last bar is provisional.
RSI: It is at 64.91, below the 70 overbought line. It peaked at 65.49 on 2026-10-20, with no divergence yet. Strong rebounds can stay at 65 to 75 without reversing.

5. Trend strength (ADX)¶

Strength: ADX is 31.31, up from 10.94 on 2026-10-08. That is a fast shift from range-bound to trending, and it confirms the move is directional.
Direction: ADX doesn't show direction. Price has risen since 2026-09-29, so the strength is on the upside. ADX also read 34.7 on 2026-09-29 during the preceding down-leg. A high ADX therefore says the move is strong, not that it will last.
Caveat: I did not pull +DI and -DI to confirm the direction.

6. Volatility and range position¶

Bollinger bands: The middle is 298.19, the upper is 343.90 and the lower is 252.48. The close sits about 2.8% below the upper band, near the top of the band range (roughly 0.90 on a 0 to 1 scale). Recent highs of 340.72 (2026-09-14) and 341.79 (2026-10-20) both stopped under the upper band.
ATR: It is 12.10, about 3.6% of price, and has eased from 14.34 on 2026-09-22. As arithmetic only, 1.5x ATR is about 316 and 2x ATR is about 310 from the current price. Those levels sit near the 319 to 320 cluster and the 310.44 close of 2026-10-14.

7. Volume (OBV)¶

Slope: OBV rose from -88.0M (2026-09-29) to -61.1M. That is above the -64.3M reading on 2026-09-21 and just under the -60.2M reached on 2026-10-20.
Reading: Volume is confirming the rebound with no OBV/price divergence in this window. The absolute level is not meaningful, only the slope.
Last bar: The 2026-10-21 OBV dip reflects the small, probably partial, volume on a slightly lower close.

8. Exhaustion and stretch¶

Tool	Weekly	Monthly	Daily
TD-9 count	-2	-1	-9 (sell-setup complete)
Z-score	+0.93	-1.04	+1.59

TD-9: The daily count is a completed sell setup, which is a reversal watch. By my reading of the CSV, every close since 2026-10-01 has been above the close four sessions earlier. The "9" therefore doesn't depend on the provisional last bar. A completed daily 9 is a watch, not a timing signal, and the price has kept rising through it. The weekly (-2) and monthly (-1) counts are early, so higher-timeframe exhaustion is not close.
Z-score: No timeframe reaches the |z| >= 2 stretch threshold. The daily +1.59 is elevated but not extreme. The weekly +0.93 is near fair value. The monthly -1.04 shows price is still below its longer-term mean.

9. Reference levels from the data¶

These are reference points only. I'm not claiming any of them has held or failed before.

Zone	Level(s)	Source
Resistance, near	340.72 to 343.90	2026-09-14 high, 2026-10-20 high of 341.79, upper Bollinger
Resistance, next	367.51 to 371.25	200 SMA, 2026-08-24 high
Resistance, regime	390.56	Weekly SuperTrend stop
Support, first	319.04 to 319.80	10 EMA, 50 SMA
Support, second	about 298 to 301	Daily SuperTrend 298.38, Bollinger middle 298.19, 2026-10-14 low of 298.83, 2026-10-13 low of 300.80
Support, deeper	261 to 267	2026-09-28 low of 261.10, 2026-09-29 close of 266.79

10. Scenarios¶

Continuation: Price holds above the 319 to 320 cluster and closes above 343.90. The next reference points are the 200 SMA near 367.5 and the August high near 371. ADX above 25, a positive MACD histogram and a rising OBV would support this. Even then, the weekly and monthly SuperTrends stay down until 390.56 is cleared.
Pullback or exhaustion: The daily TD-9 is complete, price is near the upper band and the MACD histogram has stopped rising. Together these make a pullback toward 319 to 320 plausible, then toward 298 to 301. A daily close below 298.38 would flip the daily SuperTrend to DOWN and re-align it with the weekly and monthly trends.
Event risk: The big gaps in the data (2026-05-21, 2026-08-26) came with very large volume. The earnings calendar isn't in these tools, so check it before sizing a position.

11. Bottom line for the deciding agent¶

Evidence for the bounce: Daily trend up, MACD positive, RSI near 65, ADX at 31, OBV confirming, and price back above the 10 EMA and 50 SMA.
Evidence for caution: Weekly and monthly trends are down, the 200 SMA and weekly stop are overhead, the daily TD-9 is complete, price is near the upper band, and the MACD histogram has flattened.
My read: This looks like a strong counter-trend rally in an unresolved primary downtrend. The weekly and monthly signals carry more weight than the daily ones.
Missing inputs: The tools don't cover fundamentals, news or the earnings calendar. The 2026-10-21 bar should be re-checked after the close.

Summary table¶

Item	Reading	Interpretation
Close (2026-10-21)	334.52	Latest bar, probably partial (volume 951,640)
Weekly SuperTrend	DOWN, stop 390.56	Primary trend bearish
Monthly SuperTrend	DOWN, stop 561.87	Regime bearish
Daily SuperTrend	UP, stop 298.38	Short-term bounce, 12.11% above stop
10 EMA / 50 SMA	319.04 / 319.80	Price above both; first support cluster
200 SMA	367.51	About 9.9% overhead; 50 SMA still below it
MACD / signal / histogram	6.10 / -0.11 / 6.21	Bullish; histogram peaked at 6.41 on 2026-10-20
RSI	64.91	Strong, below 70
ADX	31.31	Strong trend; up from 10.94 on 2026-10-08
Bollinger (lower / mid / upper)	252.48 / 298.19 / 343.90	Price near the upper band
ATR	12.10 (about 3.6% of price)	Volatility easing from 14.34 on 2026-09-22
OBV	-61.1M (from -88.0M on 2026-09-29)	Confirms the rebound; no divergence
TD-9 (W / M / D)	-2 / -1 / -9	Daily sell setup complete; higher timeframes early
Z-score (W / M / D)	+0.93 / -1.04 / +1.59	No timeframe stretched (
Key resistance	340.72 to 343.90, 367.51 to 371.25, 390.56	Band and prior highs, then 200 SMA, then weekly stop
Key support	319 to 320, 298 to 301, 261 to 267	EMA/SMA cluster, then SuperTrend and mid-band, then September lows

Sentiment Analyst¶

Overall Sentiment: Mildly Bullish (Score: 6.0/10) Confidence: Medium

Scope and data quality. Window: 2026-10-14 to 2026-10-21, ticker INTU (Intuit Inc.). Two of three sources returned data. News is 20 Yahoo Finance headlines with titles and links only, so there are no article bodies and no analyst figures beyond what the titles state. StockTwits is 30 messages. Reddit was disabled by configuration, so there is no Reddit read at all. That limits robustness, so confidence is medium rather than high.

1. Source-by-source breakdown

News (institutional framing, event-driven; net mildly positive with a cautionary undertone). The dominant event is Intuit's agreed acquisition of Sequence, an AI-powered revenue-automation/revenue-management platform aimed at mid-market customers. It is covered by Zacks ('to Acquire Sequence to Boost AI-Powered Mid-Market Offerings'), Benzinga, Barchart ('Intuit Stock Pops on Sequence Acquisition News'), CFO Dive ('deal signals bet on AI demand in revenue management') and Barron's ('Intuit Stock Jumps on AI Deal'). That is at least five headlines on one catalyst, and several describe a positive price reaction. A StockStory item ('Why Intuit (INTU) Stock Is Trading Up Today') and a sector item ('monday.com, Adobe, DocuSign, Intuit, and MongoDB Stocks Trade Up') point to a broad software bounce alongside the company-specific news. Zacks adds 'Intuit (INTU) Outperforms Broader Market'. Product and partner flow is also constructive: Credit Karma Tax (free federal filing with faster refunds, per Business Wire), Intuit Intelligence now available internationally (PR Newswire, echoed by Simply Wall St. 'How Investors Are Reacting To Intuit (INTU) Global AI Rollout'), and an expanded AI advisory partnership with Aprio. Valuation and analyst framing leans positive: Zacks 'Wall Street Analysts Think Intuit (INTU) Could Surge 26.36%' implies consensus targets well above the price, and 'INTU vs. MSFT: Which Stock Is the Better Value Option?' frames INTU as a value candidate. I cannot see the bodies, so I cannot confirm the basis for either. The cautionary items are a StockStory piece titled '3 Reasons to Sell INTU and 1 Stock to Buy Instead', Barron's noting the stock is 'still facing its worst year since 1996' despite the jump, and Insider Monkey asking whether Credit Karma can 'grow beyond the lending cycle'. Three of the 20 headlines (Yoodli Inc. Power Partner, BayAreaCMO ORBIE Awards, the SAP/Accenture/Moody's stock-report roundup) are marginal or off-topic and carry little signal.

StockTwits (fast retail signal; bullish, but thin and concentrated). Of the 30 most recent messages, 12 are tagged Bullish (40%), 0 Bearish (0%) and 18 have no label. The zero-bearish count is notable, but the labeled base is only 12 messages, and those come from about 9 unique authors (@caesars23 posted three bullish tags, @BigD123 two). It is a modest sample, not a broad consensus. It is also not the 90/10+ extreme that would suggest contrarian over-extension, since 60% of messages carry no stance. Substance of the posts: - Momentum and reaction: 'Boom', 'holyyyyyy', 'what is this meme coin move lol' (Oct 19-20) point to a sharp, attention-grabbing upmove. One user asked 'why the pre-market dip?' on Oct 19. The timing is consistent with the Sequence news, but the messages do not name the cause. - Technicals as cited by users (unverified): defense of the monthly 200MA, a possible double bottom on the weekly chart, 'two chances at $270' that were missed, a call trigger on a close above $340 with targets near $405, and a hope to 'finish over 325' on Oct 16. One holder is up about 20% since buying in September and plans to sell as price approaches 400. This implies the stock has rebounded roughly from the low $270s to the low-to-mid $300s or higher, with $400 as a crowded profit-taking level. - Fundamental and thesis posts: bulls cite a 'compliance moat', consistent dividend increases, 'decent management during a period of massive change' and positioning to capitalize on AI. One post tagged Bullish still concedes 'structural uncertainty' and higher execution risk. Rotation chatter favors beaten-down SaaS names (HUBS, MNDY, ADBE, CRM, NOW) as the stocks 'still well below highs'. - Competition: on Oct 20 two users flagged Google's Gemini expanding AI-powered financial analysis for small businesses as a competitor to traditional accounting software and to INTU. A counter-post argued AI platforms are probabilistic and will connect deterministic systems like tax and accounting software rather than replace them, so INTU benefits. - Credit Karma Tax: a user summary notes $0 federal and $15 per state, with paid expert add-ons at $29 and $39, and FY27 TurboTax-related growth guided at 2-3%. The user's wording is ambiguous and the figures are unverified, but the reading is that growth in the core consumer tax franchise is modest.

Reddit. Disabled by configuration; no data. No inference can be drawn about r/wallstreetbets, r/stocks or r/investing sentiment.

2. Cross-source divergences and alignments - Alignment: news and StockTwits both center on the Sequence/AI narrative and on a sharp upward price move. Both treat AI as a growth lever for INTU (mid-market revenue automation, Intuit Intelligence, Credit Karma AI assistance) rather than as purely a disruption risk. - Partial divergence: news framing is more balanced than retail. Institutional-style items carry explicit skepticism (the 'reasons to sell' headline, the 'worst year since 1996' context, a question mark over Credit Karma's durability), while StockTwits is almost uniformly constructive in its tags. Retail appears to be leaning into a recovery and a double-bottom thesis, while the news flow keeps reminding readers that the drawdown has been deep. - Within-retail tension: unlabeled posts raise the Google Gemini competition issue, while labeled bullish posts dismiss it. That AI-substitution debate is the main unresolved bull/bear fault line.

3. Dominant narrative themes 1. AI as a growth driver via the Sequence acquisition and the international rollout of Intuit Intelligence. 2. A beaten-down software name bouncing: sector-wide upmoves, 'still below highs' rotation, and a retail double-bottom/200MA-defense story. 3. AI disruption risk versus moat: Google Gemini versus INTU's compliance and deterministic-accuracy moat. 4. Consumer franchise competition and pricing: Credit Karma Tax's free federal filing alongside TurboTax, and the durability of Credit Karma beyond the lending cycle. 5. Valuation upside: analyst-target upside of about 26% per the Zacks headline, and value comparisons to MSFT.

4. Catalysts and risks surfaced by the data Catalysts / supports: Sequence deal integration and any further AI-product announcements; international Intuit Intelligence adoption; the Credit Karma Tax launch ahead of tax season; partner expansion (Aprio); continued rotation into oversold SaaS; retail-cited technical triggers (a close above about $340, with about $405 as a stated target). No earnings date is provided in the supplied data, so I cannot cite an earnings catalyst. Risks: the stock is described as having its worst year since 1996, so the rebound could be a relief bounce within a downtrend; competitive AI entrants such as Google Gemini for small-business financial analysis; free-filing cannibalization risk between Credit Karma Tax and TurboTax, plus the modest 2-3% growth cited for the tax franchise; Credit Karma's lending-cycle sensitivity; acquisition execution risk; retail crowding near $400 (stated exit level) and the 'meme coin move' language, which hints at momentum chasing; and thin evidence behind the 'Sell' and '26% upside' framings, since only headlines were provided.

5. Caveats. The StockTwits sample is small (30 messages, 12 labeled, repeat authors). News is headline-only. Reddit is absent. Price levels and financial figures quoted by retail users are unverified. Sentiment is a signal for the trader to weigh against fundamentals and technicals, not a price forecast.

6. Summary table

Signal	Direction	Source	Evidence
Sequence acquisition (AI revenue automation)	Bullish	News (Zacks, Benzinga, Barchart, CFO Dive, Barron's)	At least 5 headlines; 'Stock Pops', 'Jumps on AI Deal'
Product and AI rollout	Mildly Bullish	News (Business Wire, PR Newswire, Simply Wall St.)	Credit Karma Tax, international Intuit Intelligence, Aprio partnership
Analyst upside and value framing	Mildly Bullish	News (Zacks)	'Could Surge 26.36%'; INTU vs. MSFT value comparison
Sector bounce and relative strength	Mildly Bullish	News (StockStory, Zacks)	'Stocks Trade Up' with ADBE, DOCU, MDB, MNDY; 'Outperforms Broader Market'
Sell-side style caution / drawdown context	Bearish	News (StockStory, Barron's, Insider Monkey)	'3 Reasons to Sell', 'worst year since 1996', Credit Karma beyond lending cycle
Retail tag ratio	Bullish	StockTwits	12 Bullish (40%) / 0 Bearish / 18 unlabeled of 30; about 9 unique bullish authors
Momentum and technical recovery	Mildly Bullish	StockTwits	'meme coin move', 200MA defense, double bottom, $340 trigger, ~$405 target, $270 lows
Google Gemini competition	Mildly Bearish	StockTwits (unlabeled)	Oct 20 posts on Gemini small-business financial analysis; counter-argument on deterministic software
Credit Karma Tax pricing and core growth	Mixed	StockTwits / News	$0 federal, $15 per state; 2-3% FY27 growth per user (unverified)
Reddit	No signal	Reddit	Disabled by configuration

News Analyst¶

INTU (Intuit Inc.) – News & Macro Report, week of 2026-10-14 to 2026-10-21¶

1. Data coverage and caveats¶

FRED macro data failed. Every call returned DATA_UNAVAILABLE, including friendly aliases (fed_funds_rate, 10y_treasury, cpi, unemployment, yield_curve, vix) and a retry with raw IDs (FEDFUNDS, DGS10). I have no verified readings for rates, yields, inflation, labor, or VIX, and I'm not estimating them. The macro section relies on prediction markets and headlines instead.
INTU news is headline-only. The tool returned titles, sources, and links, with no article text, dates, price levels, or analyst-target details. I describe only what the headlines support.
The "Intuit" prediction-market query returned nothing relevant. It gave unrelated IPO markets (Anthropic, OpenAI, Databricks, and others). I'm treating it as no INTU-specific market.

2. Company news: Intuit (INTU)¶

Catalyst: Sequence acquisition (AI revenue automation) - Multiple outlets covered it: Zacks, Benzinga, Barchart, CFO Dive, StockStory, and Barron's. - Headlines say Intuit will acquire Sequence to strengthen AI-powered, mid-market offerings in revenue management and automation. - Barchart's headline says the stock "pops" on the news. Barron's says INTU jumped but is "still facing its worst year since 1996." - Read-through: the deal is a strategic push up-market, toward QuickBooks mid-market and revenue-automation workflows. The market liked it, but the stock is deeply down for the year. The rally looks like relief within a broader drawdown, not a confirmed trend change. I can't verify the deal price, size, or closing timeline from these results.

Product and AI rollout - Intuit Intelligence launched internationally on a "unified platform" for businesses and accountants. Simply Wall St. ran a piece on how investors are reacting to the global AI rollout. - Aprio (an advisory/accounting firm) broadened its AI-powered advisory partnership with Intuit for mid-market clients. This supports the mid-market narrative and the accountant channel. - Credit Karma Tax launched with free federal filing and faster refunds. This is a competitive move in consumer tax ahead of the 2027 filing season. It could pressure paid TurboTax tiers if it pulls share from free-file competitors, or it could feed Credit Karma's monetization funnel. The headlines don't say which. An Insider Monkey piece also asks whether Credit Karma can grow beyond the lending cycle, which points to its sensitivity to credit conditions.

Sentiment and valuation signals - Zacks: "Wall Street Analysts Think Intuit Could Surge 26.36%". This is the consensus target-implied upside, so sell-side targets sit well above the price. Several other Zacks items say INTU is outperforming the market and drawing investor attention. - StockStory: "3 Reasons to Sell INTU and 1 Stock to Buy Instead" is a bearish counterpoint. A separate StockStory piece says Adobe, DocuSign, Intuit, monday.com, and MongoDB traded up together, which suggests a sector-wide software bounce. - Zacks "INTU vs. MSFT: Better Value?" shows investors are comparing INTU's valuation to large-cap software after the de-rating. - Sector context: CFO.com's list of market-value losers since 2021 includes PayPal, Nike, and Zoom. The "Model Moats" piece reflects the theme that AI could commoditize software. This is likely the main drag on application-software multiples, INTU's included.

Net company read: the news flow is constructive on strategy (AI, mid-market, international expansion, tax product moves). The stock is still in a historically bad year, and the sector narrative is AI disruption risk against AI monetization. No earnings release appeared in this window. INTU's fiscal Q1 report has historically come in late November, but the tools did not confirm that date, so verify it.

3. Macro and market backdrop¶

Prediction markets (Polymarket): - No Fed cuts in 2026: Yes 97% (about $9.0M volume). Markets for 6 to 12+ cuts are priced at about 0%. - December 2026 FOMC (resolves 2026-12-09), each about $1M volume: - 25 bp cut: 1% - No change: 18% - 25 bp hike: 78% - 50+ bp hike: 2% - 50+ bp cut: 0% - US recession by end of 2026: 8% (about $2.3M volume). UK recession is 6% and Japan 4%, both on very thin volume. - Tariffs: the US–Canada tariff-reduction deal by Oct 31 is 5%, and by Dec 31 is 40%. Volumes are small. The odds of Trump raising tariffs on Canada by Oct 31 are 18%, and of lowering them are 14%.

Interpretation: - The 78% December-hike pricing is a significant signal that the market is leaning toward tightening, not easing. I could not cross-check it against FRED (fed funds, CPI, yields), so verify it before relying on it. The cut and hike markets are internally consistent, but each December market has only about $1M of volume. - For long-duration growth and software stocks like INTU, a hiking bias raises the discount rate and is a valuation headwind. The low recession odds (8%) argue against a demand shock to small-business and consumer finance. - Credit Karma is sensitive to credit and lending conditions. Higher-for-longer or rising rates could weigh on lending-marketplace revenue. QuickBooks' small-business exposure is sensitive to small-business credit and activity.

Global headlines this week: - Traders were awaiting Meta and Tesla earnings, and IBM Q3 earnings were expected to show about 8% EPS growth. Big-tech AI capex and enterprise-software commentary could move software sentiment. - Gold futures edged up while oil slipped. This is a mixed signal: mild safe-haven or rate-uncertainty demand alongside easing energy inflation. - The AI theme dominated: Procore–IBM, document-AI market forecasts, and the "model moats" debate about AI commoditization.

4. Trading implications for INTU¶

Event-driven bounce, not a confirmed reversal. Sequence lifted the stock, but Barron's notes the worst year since 1996. Watch whether the gains hold or fade.
Rate risk is the main macro variable. If the 78% December-hike pricing is accurate, expect pressure on software multiples. Confirm with actual yield and fed funds data.
Sector beta. INTU moved with ADBE, DOCU, MDB, and MNDY. Sector AI-disruption headlines and big-tech earnings may drive INTU as much as company news.
Valuation versus sentiment. Consensus-implied upside of about 26% and the INTU-vs-MSFT value comparisons support a "cheap relative to history" case. StockStory's sell call is the counter.
Seasonal and product watch. The Credit Karma Tax free-filing launch and the tax season ahead are things to track for TurboTax share and pricing. The next earnings date, likely late November, is the next hard catalyst.

5. Summary table¶

Category	Key point	Evidence / source	Implication for INTU	Confidence
Company catalyst	Intuit to acquire Sequence (AI revenue automation, mid-market)	Zacks, Benzinga, Barchart, CFO Dive, Barron's	Strategic up-market push. Stock popped, but deal terms are unverified.	Medium (headlines only)
Stock context	Worst year since 1996 despite the bounce	Barron's	The rally may be relief within a downtrend.	Medium
Product	Intuit Intelligence launched internationally	PR Newswire, Simply Wall St.	Expands the AI platform's addressable market.	Medium
Product	Credit Karma Tax: free federal filing, faster refunds	Business Wire	Competitive tax move. Could affect TurboTax mix or feed the Credit Karma funnel.	Medium
Partnership	Aprio expands AI advisory partnership	PR Newswire	Supports the accountant channel and mid-market narrative.	Medium
Analyst view	About 26% upside to consensus targets	Zacks	Sell-side is bullish relative to the price.	Medium
Bearish view	"3 Reasons to Sell INTU"	StockStory	Valid counter-narrative.	Low–Medium
Sector	Software names rallied together (ADBE, DOCU, MDB, MNDY, INTU)	StockStory	Sector beta is significant.	Medium
Sector risk	AI commoditization of software ("model moats")	Forkast, CFO.com	Multiple-compression risk.	Medium
Fed policy	No 2026 cuts at 97%. December: hike 78%, hold 18%, cut 1%.	Polymarket	Rate headwind for long-duration growth. Needs FRED verification.	Medium (thin volume, unverified)
Recession	US recession by end of 2026 at 8%	Polymarket	Low odds of a demand shock.	Medium
Tariffs	US–Canada deal by Oct 31 at 5%, by Dec 31 at 40%	Polymarket	Limited direct INTU impact, but a macro noise factor.	Low (thin volume)
Earnings backdrop	Meta, Tesla, and IBM earnings this week	MT Newswires, Benzinga	Big-tech AI commentary may sway software sentiment.	Medium
Commodities	Gold up, oil down	WSJ	Mixed signal on inflation and safe-haven demand.	Low
Macro data	FRED series (rates, CPI, unemployment, VIX, curve) unavailable	Tool errors	No verified macro readings. Another source is needed.	n/a
Upcoming	Next INTU earnings, likely late November (not tool-confirmed)	Historical pattern	The next hard catalyst. Verify the date.	Low

Fundamentals Analyst¶

INTU (Intuit Inc.): Fundamental Report¶

Date: 2026-10-21 | Sector: Technology, Software – Application | Exchange: NMS | Fiscal year-end: July 31

1. Bottom line¶

Operations: The FY26 10-K (year ended 7/31/2026) shows revenue up 13.9%, operating income up 19.5% and EPS up 20.4%. Operating margin reached 27.4%, a multi-year high.
Price: The stock is down about 51% from its 52-week high of $689.17. The market cap/EPS-based price is about $334.50. That puts it 4% above the 50-day average ($321) and 10% below the 200-day average ($372).
Valuation: It has compressed to 20.3x trailing and 12.4x forward earnings. The forward figure is probably not comparable to the trailing one (see §8).
Debate: The key question is whether growth in the tax-season quarter (fiscal Q3) is slowing for good. Q3 revenue growth fell to 10.4%, from 18% in fiscal Q1 and 17% in fiscal Q2.
Insiders: There has been no meaningful insider selling since the January 2026 CEO sale. One director bought in the open market near the lows (May 2026).
Past week: I found no new filings or insider transactions in the last 7 days. The latest insider entries are dated 2026-10-01.

2. Snapshot (from `get_fundamentals`)¶

Metric	Value
Market cap	$89.4B
Implied price	About $334.5 (EPS 16.46 × P/E 20.32 and 26.94 × 12.42 both give $334.5)
P/E (TTM) / Forward P/E / PEG	20.3x / 12.4x / 1.03
Price/Book / Book value per share	4.73x / $70.76
EPS (TTM) / Forward EPS	$16.46 / $26.94
Dividend yield / Beta	1.65% / 1.01
Revenue (TTM) / Gross profit	$21.45B / $17.37B (gross margin about 81%)
EBITDA / Net income	$6.85B / $4.57B
Profit margin / ROE / ROA	21.3% / 23.6% / 10.5%
Debt/Equity / Current ratio	0.44x / 1.51
52-week range	$252.84 – $689.17

Derived valuation figures: - Price/Sales is about 4.2x. - Enterprise value is about $93B, assuming debt of about $8.4B (0.4434 × $18.99B equity) and cash of $4.7B. - EV/EBITDA is about 13.6x. - Implied shares outstanding are about 267M.

3. Income statement¶

Annual (USD millions): | FY (Jul) | Revenue | YoY | Op. income | Op. margin | Net income | Diluted EPS | |---|---|---|---|---|---|---| | FY22 | 12,726 | – | 2,571 | 20.2% | 2,066 | 7.28 | | FY23 | 14,368 | +12.9% | 3,141 | 21.9% | 2,384 | 8.42 | | FY24 | 16,285 | +13.3% | 3,630 | 22.3% | 2,963 | 10.43 | | FY25 | 18,831 | +15.6% | 4,923 | 26.1% | 3,869 | 13.67 | | FY26 | 21,448 | +13.9% | 5,884 | 27.4% | 4,566 | 16.46 |

Long-run growth: Revenue CAGR is about 14.3% over 3 years and about 17.4% over 5 years. The 5-year figure includes the Mailchimp acquisition, which shows up as the FY22 jump in total assets.
Share count: Diluted shares fell about 2% (about 283M to about 277M), derived from net income divided by EPS. That is why EPS grew faster than net income.

Fiscal 2026 vs. 2025 by quarter. Q4 is derived as the annual figure minus the three reported quarters. It is not a reported number. | Quarter | Revenue | YoY | Op. income | YoY | Net income | EPS (FY26 vs FY25) | |---|---|---|---|---|---|---| | Q1 (Oct) | 3,885 | +18.3% | 534 | +97% | 446 | 1.59 vs 0.70 | | Q2 (Jan) | 4,651 | +17.4% | 855 | +44% | 693 | 2.48 vs 1.67 | | Q3 (Apr) | 8,558 | +10.4% | 4,020 | +8.1% | 3,064 | 11.09 vs 10.02 | | Q4 (Jul), derived | about 4,354 | about +13.7% | about 475 | about +40% | about 363 (vs 381, −5%) | about 1.30 vs about 1.28 |

Key reads: - Seasonality: Q3 produced about 40% of revenue and about 67–68% of operating income and net income. Results hinge on tax season. - Q3 slowdown: Q3 growth was 10.4%, with margin slipping from 48.0% to 47.0%. This is the weakest growth of the year in the biggest quarter, and it is the likely driver of the price decline. The tools don't state a cause, so that is my inference. - Cost leverage: The off-season quarters (Q1, Q2 and derived Q4) showed strong operating income growth, which suggests expense discipline. - Q4 net income: It fell about 5% despite higher operating income. I can't explain that from this data (possibly tax or other income).

4. Cash flow and capital allocation¶

FY	Op. cash flow	Capex	FCF (OCF − capex)	Investing	Financing
FY24	4,884	191	4,693	−227	−397
FY25	6,207	84	6,123	−2,318	−1,510
FY26	8,838	175	8,663	−1,412	−7,689

Cash generation: FY26 operating cash flow rose 42%. FCF margin was about 40% (FY25: 32.5%), and FCF was about 1.9x net income.
Fiscal Q4 cash flow: Q4 operating cash flow was about +$1.33B, derived from the annual figure less the 9-month figure of $7,507M. Q4 FY25 was +$381M.
Buybacks: Financing outflow was −$7.7B, about 87% of operating cash flow. Roughly $3.7B of it came in fiscal Q4 alone, against about $4.0B in the first nine months. That points to accelerated repurchases and/or debt paydown at the lows. The tools don't split buybacks, dividends and debt.
Equity: Equity dropped $1.64B in Q4 (20,629 to 18,992), consistent with heavy buybacks.
FCF discrepancy: The fundamentals feed lists TTM FCF at $6.35B. The SEC-derived figure is $8.66B. I can't reconcile the two.
On market cap, FCF yield is about 7.1% (conservative) or about 9.7% (SEC-derived).
Use the lower number for conservative modeling until it is checked against the 10-K.

5. Balance sheet (7/31/2026 vs 7/31/2025, USD millions)¶

Item	Jul-26	Jul-25	Change
Cash & equivalents	4,705	2,884	+63%
Current assets	15,311	14,107	+8.5%
Total assets	36,786	36,958	−0.5%
Current liabilities	10,163	10,370	−2.0%
Total liabilities	17,794	17,248	+3.2%
Stockholders' equity	18,992	19,710	−3.6%

Leverage: Debt/equity is 0.44x, or about $8.4B of debt. Net debt is about $3.7B, roughly 0.5x EBITDA. Leverage is modest.
Liquidity: The current ratio is 1.51 and cash is up 63%.
Customer funds: Intuit's current assets and liabilities typically include customer-fund balances (e.g., payroll), which inflate both sides. The tools don't break this out, so treat the current ratio with care.
Intangibles: Goodwill and intangibles from Mailchimp are not itemized in the output.

6. Insider activity¶

The "Transaction" field is blank on every row. I classified rows from the notes (sale, purchase, conversion) and the Ownership code (D = direct, I = indirect).

Recent (since March 2026): | Date | Insider | Action | Detail | |---|---|---|---| | 2026-05-26 | Vasant Prabhu (Director) | Open-market BUY | 1,750 sh at about $309.5 (about $542K). Only open-market purchase in the whole dataset | | 2026-03-12 | R. Dalzell (Director) | Sale | 999 sh at $440–474 (about $457K) | | 2026-06-11/16/23 | Dalzell | Sales | About 1,572 sh at $262–298 (about $444K) | | 2026-08-27 | L. Hotz (Officer) | Sale | 906 sh at about $346 (about $314K) | | 2026-09-08 | Dalzell | Sale | 285 sh at $325.36 (about $93K) | | 2026-10-01 | CEO, CFO, GC and other officers | No price/value | Routine monthly or quarterly entries. Likely equity-compensation events (e.g., vesting or tax withholding), but the data doesn't say |

Selling since April 2026 totals about $0.85M against about $0.54M of buying, which is small.

Earlier, large (context): - Scott Cook (founder/director): He sold about 494K shares in Dec 2025 for about $327.5M, at $632–678. Over Feb–Dec 2025 the dataset shows roughly $530M of total sales. He made no sales in 2026, only a 30,750-share gift on ⅛/2026. - CEO Sasan Goodarzi: He sold 41,000 shares at about $650 on 1/7/2026 for $26.65M (indirect). - CFO Sandeep Aujla: He made regular small sales of $0.7–0.8M (Oct 2025, Dec 2025, Jan 2026). - Directors (Szkutak, Dalzell, Burton): They made small derivative-security conversions each quarter, about $25–30K each.

Reading: the large insider selling was at prices roughly double today's. Recent selling is small and looks programmatic, with Dalzell's quarterly sales of about 1,000 shares. The one discretionary buy came right after fiscal Q3 results, which is my inference from the typical reporting calendar.

7. Risks and watch items¶

Tax-season dependence: About two-thirds of profit comes from one quarter. The Q3 slowdown to 10.4% is the key risk, and Q3 FY27 (Feb–Apr 2027) is the next big test.
Margin in the peak quarter: Q3 operating margin fell about 100 bps year over year.
Q4 net income: It fell about 5% despite higher operating income (derived).
Cash-flow quality: OCF is about 1.9x net income, and the FCF sources disagree ($6.35B vs $8.66B).
Equity shrinking: Heavy buybacks lowered book equity 3.6% year over year. That is supportive of EPS but reduces the cushion.
Trend: The 50-day average ($321) is below the 200-day ($372), a downtrend signature, though price is now above the 50-day.
Catalysts: Fiscal Q1 FY27 earnings are likely in late November, based on historical cadence rather than tool data. Then the FY27 guidance path and buyback pace.

8. Data caveats¶

Cost of revenue and gross profit aren't tagged in the SEC income statement. I used the fundamentals feed's gross profit of $17.37B (about 81% margin).
Quarterly cash flow is cumulative year to date (3, 6 and 9 months), so I derived Q4 figures by subtraction.
Operating margin mismatch: The fundamentals feed lists 17.6%, while FY26 SEC data gives 27.4%. I can't reconcile them and used the SEC figures.
Forward EPS mismatch: Forward EPS of $26.94 is 64% above trailing GAAP EPS of $16.46. It is probably a non-GAAP consensus figure that excludes stock compensation and amortization. If so, the 12.4x forward P/E is not like-for-like with the 20.3x trailing P/E. Treat it as flattered until checked.

9. Summary table¶

Category	Key point	Implication
Growth	FY26 revenue $21.45B (+13.9%); 3-year CAGR 14.3%	Durable double-digit growth, but Q3 slowed to +10.4%
Profitability	Operating margin 27.4% (FY25: 26.1%); EPS $16.46 (+20.4%)	Strong operating leverage
Seasonality	Q3 is about 40% of revenue and about 67% of profit	Results and stock hinge on tax season
Cash flow	OCF $8.84B (+42%); FCF $8.66B SEC-derived vs $6.35B feed	Strong but needs verification; use the lower figure to be conservative
Capital return	Financing outflow −$7.7B, about $3.7B in Q4 alone; share count down about 2%	Aggressive buyback near the lows; supports EPS
Balance sheet	Cash $4.7B; D/E 0.44x; current ratio 1.51; net debt about $3.7B	Healthy and flexible
Valuation	P/E 20.3x; forward P/E 12.4x (likely non-GAAP); PEG 1.03; P/S about 4.2x; EV/EBITDA about 13.6x	Compressed vs. history; forward multiple likely flattered
Price action	About $334.5; −51% from high; above 50-day, below 200-day	Recovering from lows but in a longer downtrend
Insiders	Cook sold about $327.5M (Dec 2025) and the CEO $26.7M (Jan 2026) at about $650; director bought $542K at about $310 (May 2026); recent sales small	No recent distribution; one discretionary buy
Key risks	Q3 deceleration, tax-season concentration, FCF and forward-EPS data conflicts	Watch fiscal Q1 FY27 results and Q3 FY27

Fundamental read: The operating results, balance sheet and capital return are strong. The price decline reflects doubt about growth durability, not deteriorating financials. The trade decision is left to the next agent.

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # INTU Bull Case: A Compounding Franchise at a Half-Price Multiple

The bear case is easy to write: the stock is down about 50% in a year, it's having its "worst year since 1996," and the weekly and monthly trends are down. I'll concede all of that up front. But a stock falling 50% while EPS grows 20% is a valuation reset, and I think the market overshot.

1. The business kept compounding while the stock halved¶

FY26 (year ended 7/31/2026), straight from the filings: - Revenue: $21.45B, up 13.9%. The 3-year CAGR is about 14.3%. - Operating income: $5.88B, up 19.5%. Operating margin hit 27.4%, up from 26.1% and 20.2% in FY22. - EPS: $16.46, up 20.4%. - Operating cash flow: $8.84B, up 42%.

A year ago the stock was at $665, about 49x FY25 EPS of $13.67. Today it's $334.52, about 20x FY26 EPS of $16.46. Earnings rose 20% and the multiple fell by more than half. That gap is the opportunity. The PEG is about 1.0, EV/EBITDA is about 13.6x, and the forward P/E is 12.4x. I'll flag that the forward figure is probably non-GAAP and flattered, so I'm anchoring on the 20x trailing GAAP number. That's still cheap for a business with 81% gross margins and double-digit growth.

2. Cash flow and capital allocation¶

Even using the conservative feed figure of $6.35B in free cash flow, the FCF yield is about 7.1%. The SEC-derived $8.66B implies about 9.7%. I can't reconcile the two, so I'll use the low one, and it's still a very attractive yield.

Management is also acting on that value: - Financing outflows were $7.7B for the year, about $3.7B of it in fiscal Q4 alone, right as the stock was bottoming. The tools don't split buybacks, dividends and debt paydown, but equity fell $1.64B in Q4, which fits heavy repurchases. - Diluted share count is down about 2%. - Even after all that, cash rose 63% to $4.7B. Debt/equity is 0.44x and net debt is about 0.5x EBITDA. The company funded the buyback from cash flow and didn't strain the balance sheet.

3. Moat and strategy¶

This franchise sits on tax and accounting workflows where accuracy and compliance are the product. One StockTwits bull put it well: AI platforms are probabilistic, and they'll connect to deterministic systems like tax and accounting software rather than replace them. Intuit's response to AI is to build and buy: - Sequence acquisition: AI-powered revenue automation aimed at the mid-market. This is a push up-market from the small-business base. Deal terms aren't in our data, but the market's reaction was positive (Barchart: "Stock Pops"; Barron's: "Jumps on AI Deal"). - Intuit Intelligence has gone international on a unified platform. - Aprio expanded its AI advisory partnership, which strengthens the accountant channel. - Credit Karma Tax with free federal filing builds the top of the funnel for the broader Credit Karma ecosystem.

4. The tape is starting to agree¶

Higher low: The September low of 266.79 sits above June's closing low of 252.77, and the stock is up about 25% from there in 16 sessions.
Momentum: The daily SuperTrend is UP. The MACD histogram is positive at 6.21 and RSI is 64.91, below overbought. ADX jumped from 10.94 to 31.31, so the market went from drifting to trending.
Volume: OBV rose from -88.0M to -61.1M with no divergence, so the rally is being bought.
Moving averages: Price is above both the 10 EMA (319.04) and the 50 SMA (319.80).
Sentiment: StockTwits showed 12 bullish and 0 bearish tags. It's a small sample, so I won't oversell it. Zacks cites consensus-implied upside of about 26%, which would be roughly the low $420s from here. I can't see the basis for that, so I treat it as supportive color only.

5. Where I expect the bear to push, and my response¶

"Q3 growth slowed to 10.4%, so growth is structurally decelerating." It's the biggest quarter, so it matters, and I won't pretend otherwise. But fiscal Q1 was +18.3% and Q2 was +17.4%. Derived Q4 is about +13.7%, which is a re-acceleration from Q3. Full-year growth was 13.9%, and Q3 operating income still grew 8.1% to $4.0B. One soft quarter is a data point, not a trend, and a 20x multiple already prices in a slowdown. The next real test is Q3 FY27 in spring 2027. Until then, we get paid a 7%+ FCF yield to wait.

"AI will commoditize software, and Gemini is already targeting small-business finance." This is the real fault line, and it's unresolved. But a stock that fell 50% already discounts a lot of that fear. Tax and accounting depend on compliance, trust and accuracy, and that is where a probabilistic model is weakest. Meanwhile Intuit is buying AI capability (Sequence) and shipping it (Intuit Intelligence), not standing still.

"Credit Karma Tax is free filing, so it will cannibalize TurboTax, and TurboTax growth is only 2–3%." That 2–3% figure comes from one unverified user post, so treat it with caution. Free federal filing is a funnel, not a giveaway: the post cites paid expert add-ons at $29 and $39 and $15 per state, and Credit Karma monetizes through its wider platform. The cannibalization risk is real, and it is the thing to watch in tax season. The stock is now priced for that risk.

"The weekly and monthly SuperTrends are still DOWN, the 200 SMA is overhead and the daily TD-9 is complete." All true, and I won't hide from it. The weekly regime flips on a close above 390.56, and the 200 SMA is at 367.51. But trend indicators lag, so they are the last thing to turn at a bottom. The TD-9 is a watch, not a timing signal, and price has kept rising through it. The weekly (-2) and monthly (-1) counts are early, and the daily z-score of +1.59 is below the 2.0 stretch threshold. A pullback to the 319–320 cluster would be healthy consolidation. My thesis rests on valuation and earnings power, and the chart is secondary confirmation.

"Rates: Polymarket has a 78% chance of a December hike." That market has about $1M in volume, and FRED data wasn't available to cross-check it. I'd treat it with caution. Even if it's right, this isn't a 50x-multiple long-duration story. It's a 20x P/E stock with a 7%+ FCF yield and modest leverage. The same market prices only 8% odds of a US recession, so the demand backdrop for small businesses and consumers looks intact.

"Insiders were sellers." Scott Cook sold about $327.5M in Dec 2025 at $632–678, and the CEO sold $26.65M at about $650 in January. That was at nearly double today's price, and it was diversification at the top. Cook made no sales in 2026. Since April, insider selling totals about $0.85M and looks programmatic, against a $542K open-market director purchase at about $309.5 in May. The one discretionary buy came near the lows.

6. What would prove me wrong¶

I'll be clear about the risks. About two-thirds of profit comes from one quarter, so a weak Q3 FY27 would hurt. A daily close below 298.38 flips the daily trend back to DOWN. Failing at the 340–344 resistance zone would suggest the bounce is only a relief rally. Also, the FCF and forward-EPS data conflicts need to be checked against the 10-K.

But the setup is asymmetric: a high-quality compounder with 27% operating margins, a 7%+ FCF yield, a shrinking share count and a balance sheet that funded a $7.7B financing outflow, trading at 20x trailing earnings after a 50% drawdown. The next catalyst is the fiscal Q1 report, likely in late November, though that date isn't confirmed by our tools.

So, bear, which of these do you want to take on first: the Q3 deceleration, or the AI-disruption thesis? Bull Analyst: # INTU Bull Rebuttal: The Bear's Base Case Is My Floor Scenario

I checked your arithmetic and most of it holds, so I'll start with what I'm giving up. That leaves three real disagreements.

What I concede¶

Profit mix: Your split is right. Q3 added about $301M of operating income and the other three quarters about $660M.
Trailing multiple: Derived Q4 EPS was roughly flat (about $1.30 vs $1.28), so trailing EPS barely moved from the June low. The 15.4x to 20.3x move is a re-rating on trailing numbers.
Forward P/E: I'm dropping the 12.4x. The right frame is about 18x forward GAAP.
Tape and sentiment: ADX is non-directional. The weekly and monthly trends are down. The last bar is partial. The Sequence pop was shared with ADBE, DOCU, MDB and MNDY. StockTwits and Zacks are color, not evidence.
Earlier buybacks: The Q1–Q3 repurchases were made at much higher prices. I can't defend that timing.
Late-November print: It is event risk, and I'd size for that.

1. Your $18.1–18.4 FY27 EPS is a floor scenario, not a base case¶

You grew EPS 10–12% off $16.46. But implied shares are about 267M (market cap ÷ price), against a FY26 average diluted count of about 277M. That is roughly 3–4% fewer shares before FY27 begins. The gap is loosely overstated by basic-vs-diluted differences I can't isolate. It exists because $3.7B of the financing outflow came in fiscal Q4, so the FY26 average only captures part of it.

The bridge works out like this: - Your range: With the share count merely flat from here, 10–12% EPS growth needs net income growth of only about 6–8%. That is Q3's operating-income rate (+8.1%) applied to every quarter with zero margin expansion. - Flat margins: If net income grows at Q3's 10.4% revenue rate, EPS is about $18.7–18.9, or roughly 17.7–17.9x. That is still no 12x, but it's a business growing EPS in the mid-teens at under 18x GAAP.

"Derived" Q4 also isn't weak evidence. It is arithmetic on reported annual and quarterly figures, not an estimate. It would only be soft if there were reclassifications I can't see. The −$18M Q4 net income gap you keep citing is 0.4% of annual net income. I'd check it in the 10-K, but it doesn't move the valuation.

2. Your FCF haircut makes my number better¶

You said OCF/net income could revert from 1.94x to 1.60x. Apply it: - Net income of $4,566M × 1.60 = $7.3B OCF. - Less $175M capex, FCF is about $7.1B, an 8.0% yield.

That beats the conservative $6.35B (7.1%) I was using. Your downside case on cash conversion still clears my base.

On SBC: my anchor was trailing GAAP P/E, and GAAP net income is already after stock compensation. Your point applies to the FCF yield, not to the 20.3x. I also agree buybacks partly offset SBC dilution, which is why I'd rather count it as a cost than ignore it.

3. The buyback ruler¶

You compare $7.7B (8.6% of market cap) to a 2% drop in average diluted shares. That mixes a period-end flow with a weighted average. The point-in-time count is down about 3–4% by my numbers above. Dividends at a 1.65% yield also take roughly $1.5B a year, and some of the outflow may be debt paydown, which the tools don't split.

Going forward, about $1.5B of dividends leaves $5B+ of FCF for repurchases. At $334 that retires roughly 5–6% of shares gross of SBC issuance, about twice the shares per dollar that $650 bought. The prior $4.0B was poorly timed, but it's sunk. What matters is what the next dollar buys.

4. AI: the P&L is the test, not the 50% drawdown¶

You called "it fell 50%, so it's discounted" circular. Fair, so here is evidence instead of a price move. FY26 was the year the AI-disruption narrative took over. In it, revenue grew 13.9%, faster than FY23 (12.9%) and FY24 (13.3%). Operating margin rose 130 bps and OCF rose 42%. If agents were taking the customer relationship, it hasn't reached the reported numbers. Q3's 10.4% is a real warning and not yet proof.

On your "back-end utility" reading, a system of record that AI platforms connect to keeps the data and the compliance layer, and that's where the 81% gross margin comes from. The Aprio accountant channel and Intuit Intelligence's unified platform are the defense of that position. I can't prove it holds, but you can't prove it breaks.

On your trigger list: You want "FY27 guidance that clears the 2–3% consumer-tax worry." The tools don't date guidance. But Intuit has historically guided with its Q4 report in late August, and the user post says "guided." If so, that worry has been in the price since the Aug 26 gap and the slide to 266.79, and the stock is up 25% from there. Also, a 2–3% consumer-tax rate and a 10.4% company-wide Q3 are different measures, and we have no segment weights to combine them.

On your Q3 FY27 bar: Revenue growth above 13% means re-accelerating from 10.4% just to satisfy you. By the time that print arrives, the stock won't be at 20x. A bar for holding the multiple is Q3 growth around 10% with margin at or above 47%.

5. The tape and the price of certainty¶

You rank the weekly trend above the daily, and I accept the hierarchy. A few notes: - Higher lows: The September low (261.10 intraday, 266.79 close) held above June's (250.56, 252.77). A failed rally that holds a higher low is how bases form. Lower highs plus higher lows is compression, not a confirmed downtrend. A downtrend resumes with a lower low than June. - Double top: The 340.72 and 341.79 highs bracket a trough at 261–267. A double top confirms on a break of that trough, about 21% away, which isn't a near-term signal. The 343.90 band also moves with price and isn't fixed resistance. - Partial bar: You flag it, then cite the MACD tick from 6.41 to 6.21 and the close below the Sep 14 closing high as exhaustion. Those numbers come from the same incomplete bar.

Your confirmation levels also cost money:

Entry	Price	P/E on FY26 $16.46	P/E on your FY27 ~$18.3
Your pullback entry	298–300	18.1–18.2x	16.3–16.4x
Today	334.52	20.3x	18.3x
Weekly SuperTrend flip	390.56	23.7x	21.3x

Waiting for the weekly flip means paying 17% more for the same business. And 298–300 requires a drop of about 10–11% that may never come.

6. Insiders and rates, briefly¶

Insiders: Cook's $327.5M and the CEO's $26.65M were at about $650, nearly double today's price. Cook has made no sales in 2026, and the CEO and CFO haven't sold since January. At current prices, selling since April is about $0.85M against $0.54M bought. Dalzell's roughly 500-share quarterly sales look programmatic. The largest buyer is the company, with about $3.7B in Q4 alone.
Rates: The 97% "no cuts" market has real volume, and I concede it. But "no cuts" isn't tightening, and FRED failed, so I can't size the rate effect. Duration matters less when roughly 8% of the market cap comes back through dividends and buybacks.

Where this leaves the position¶

I'm tightening my earlier "asymmetric" claim. On levels alone, your table is roughly symmetric: about −20% to 266.79 against about +17% to 390.56. What tilts it is carry. The 1.65% dividend and an FCF and capital-return yield of about 7–8% pay me to be early. A true break of the thesis needs a lower low than June.

The plan is to scale in rather than chase: - Entry: Take a starter now and add at your own pullback levels, 319–320 and then 298–301. - Technical risk: A daily close below 298.38 means reducing. A close below about 252 means the technical case is broken. - Fundamental risk: Q3 FY27 revenue growth below about 9%, or operating margin falling again from 47%, breaks the fundamental case.

My question back to you is what Q3 FY27 looks like in your model to justify buying at 298–300. That is 16.4x your own FY27 EPS for a business with a 27.4% operating margin. And if the stock never gives you that pullback, what is your plan? Bull Analyst: # INTU Bull Close: A Fair Price, Positive Skew, Priced Risk

The bear's closing is the strongest version of that case, and the gap between us is narrow. We agree that: - FY26 reported results show no AI damage yet. - Forward GAAP P/E is about 18x on either EPS path. - Rates give no tailwind, and insider activity is noise. - Q3 FY27 is the real test.

What's left is whether a starter position now is worth it. First, what I'm giving up.

What I concede¶

The plan contradiction. Adding at 298–301 while reducing on a close below 298.38 was incoherent. I fix it in section 5.
The weekly flip. I argued against an entry rule you didn't propose. 390.56 is your regime-change marker.
The carry. My 7–8% was too high. After SBC, it is closer to 5.5–6% (see section 3).
PEG ~1.03. It doesn't survive your EPS path. At 18.3x on about 11% growth, PEG is nearer 1.6. This is a fairly priced compounder, not a bargain-bin stock, and I'm no longer calling it "asymmetric." I'm calling it positively skewed.

1. Your own table is my case¶

I'll use your 12-month table, with one row added against myself. June's trough on forward EPS was about 14x (252.77 ÷ $18.3 is about 13.8x), so a full retest is a real tail.

12-month forward multiple	Price on ~$20.3 EPS	vs. $334.52
14x (full June-trough retest)	~$284	−15%
15x	~$305	−9%
16.5x (break-even)	~$335	0%
18x (today's forward)	~$366	+9%
20x (today's trailing)	~$406	+21%

Dividends add about 1.65%. On your EPS path, which already assumes Q3 growth in the high single digits, the stock loses money only if the forward multiple a year from now is below about 16.2–16.5x. That is roughly a point above June's trough on trailing terms and well below today's 18x. You don't need a heroic re-rating to make money. You need the market not to re-price fear at its worst. If the stock holds a flat 18x, the annual return is roughly 12–13% from EPS growth plus dividend. That is a good outcome and a fair price, and I'd settle for it.

2. The AI test: what disintermediation would look like¶

You say the P&L is backward-looking and can't clear a forward risk. But an agent taking the small-business customer relationship would hit the off-season, non-tax quarters first. Here is what those show: - Q1, Q2 and derived Q4 combined: about $12.89B of revenue against about $11.08B a year earlier, about +16.4%. - The tools don't give segment splits, and Q2 and Q4 carry some tax revenue, so this isn't a clean QuickBooks read. - It is still the closest thing to a leading indicator we have, and it shows no cracks.

The visible crack is Q3 at 10.4%, and our data doesn't identify its cause. The Credit Karma Tax free-filing launch is described as ahead of the 2027 season, so it postdates Q3 FY26 and can't explain that quarter. It is a FY27 variable.

You also said the 18x buyer carries the burden of proof. But if the AI risk is only visible after customers have moved, "wait for proof" is an impossible standard. The practical question is whether 18x forward GAAP, with a share count shrinking about 3–4% net, underprices a business that reports 27% margins. Sequence and Intuit Intelligence are Intuit building into the shift rather than waiting for it, though I can't verify their results.

3. The carry, honestly¶

Forward GAAP earnings yield is about 5.5% ($18.3 ÷ $334.52), already after SBC.
Your SBC-adjusted FCF yield is 5.6–6.0%. Two independent routes land in the same place, so I'll use about 5.5–6%, not 7–8%.
If SBC runs where you assume, a gross 5–6% buyback retirement nets to about 3–4%. That matches the 3–4% point-in-time share reduction I derived earlier.
Buybacks are discretionary and only create value below intrinsic value. At 18x forward GAAP with 10%+ growth, I'm comfortable calling that a reasonable price.

4. "Wait for the 10-K and the guide"¶

The 10-K is already filed. The fundamentals report's FY26 figures come from it. The FCF, SBC and buyback split aren't a future catalyst. They are diligence we can do today, which is a reason for starter size rather than a reason to wait for a market event.
The guide. Intuit historically guides with its late-August print, though our tools can't confirm that. If so, the consumer-tax worry has been in the price since the Aug 26 gap and the slide to 266.79.
The late-November print. It is the one genuinely new input, and Q1 was only about 9% of FY26 operating income ($534M of $5,884M). A 20% Q1 operating-income miss would be under 2% of annual operating income. It is a sentiment event and a sizing issue, not a thesis event.
Your own entry rule. You'd buy after a close above 343.90 and a retest of 319–320, which means paying as much as 18.8x or more on confirmation. So the multiple isn't your objection, timing is. A starter costs little if the timing is wrong and protects the return if the stock never retests.

5. The plan, fixed¶

Step	Level	Condition
Tranche 1 (⅓)	~$334 now	Starter, sized for the print
Tranche 2 (⅓)	316–320	10 EMA / 50 SMA / ~1.5x ATR; add on a hold
Tranche 3 (⅓)	305–310, or a close above 343.90 with a held 319–320 retest	Second option is your trigger; first is ~2x ATR and the Oct 14 close
Reduce	Daily close below 298.38	Back to starter size; no adds below this level
Technical exit	Close below ~261	Higher-low failure

Fully built: average cost is about $320. Risk to 298.38 is about −7%. The base case of $366 is about +14%, and the 20x case of $406 is about +27%.
Starter only: the loss to 298.38 is −10.8% on a third of the position, about −3.6% of the full size.
Fundamental break: Q3 FY27 revenue growth below about 9%, or operating margin below 47% again. Your base case sits about a point from that line, so I'm sizing for it.
Stop-out: a 298.38 stop-out is the market asking me to wait, not a refutation of the thesis.

Verdict¶

INTU is a 27%-margin franchise whose reported numbers show no AI damage, priced at about 18x forward GAAP after a 50% de-rating. It needs only that the multiple doesn't retest fear-level pricing to deliver a low-teens return. The bear's own table shows a −9% row against +9% and +21% rows, and the −15% tail is one I added against myself. That is positive skew, not a free lunch.

I'd accumulate in scaled tranches and treat Q3 FY27 as the thesis test. The bear would accept that same stock at a higher price, after a chart signal. The disagreement is over timing a starter, not over the quality of the business or the range of fair value. Bull Analyst: # INTU Bull Close: The Last Disagreement Is Worth About 1% of a Position

You've narrowed this to one question: what a quarter of the position should pay for the right to own INTU into the print. I'll give up what's yours, then show why the remaining gap is smaller than it looks.

What I concede¶

The grid arithmetic. Equal weights give about +1.2%, or +2.9% with the dividend. My "12–13% at a flat 18x" was also too high. A flat 18.0x returns about +9.2% plus 1.65%, roughly 11%, and you need 18.3x to reach 12–13%.
Carry. The trailing earnings yield is 4.9%, and FRED failed, so I can't compare it to Treasuries. "Pays me to be early" is unproven, and the case shouldn't lean on it.
The off-season blend. My +16.4% hid the H1 to H2 slowdown, from about +17.8% to +11.5%. "Disintermediation shows up off-season first" was my assumption, not data.
Gap math and plan wording. A 20% gap on a third is −6.7% of full size, and my stop language was ambiguous. Both are fixed below.
Entry cost. The starter costs 4.5% more than 320.

1. The grid's average is just its center¶

Your five rows average 16.7x, and 16.7x × $20.3 is about $339, so the +1.2% follows from that. The average of any symmetric grid equals its center, whatever the spread:

Center multiple	Implied 12-month price return
16.5x	0%
17.0x	+3%
17.5x	+6%
18.0x	+9%

The real question is where the center belongs, and the stock's own history gives some anchors: - Since the Q3 print, trailing EPS has been $16.44–16.46, and the trailing multiple has ranged from 15.4x to 22.4x on that same earnings base. - The 50-day average ($321) is 17.5x your $18.3. The midpoint of the four-month closing range ($310) is about 17.0x. - Today's price is only 4–5% above that 50-day average, about three-quarters of a turn. The "four turns in 16 sessions" comparison starts from the lowest close in the window.

A center of 17–17.5x gives +3% to +6% in price, or about 5–8% a year with the dividend. That fits what we both said: a fair price with modest positive expectancy. It's also why this is a starter and not a full position. I don't model Sequence, Intuit Intelligence or Aprio into EPS, so they sit outside the 18x as optionality.

2. The unexplained quarter is already in your model¶

Your base case for Q3 FY27 is +9–10%, about four points below the derived Q4 exit rate (~13.7%) and below FY26's 13.9%. So you already underwrite further deceleration, and that is the $18.3 we both use. Neither of us can explain Q3. The way to price that is to size down, not to hold no position.

Your Q1 FY27 trigger, growth of 13.7% or better against an +18.3% comp, is an acceleration bar. On a two-year stack, +10% is about +30% and +13.7% is about +34.5%. A print that clears your bar would likely re-rate the stock before you could act on it. An unmet bar doesn't break the thesis either. You said the late-November print can lower conviction more easily than raise it, and I agree, which is why I'm holding a quarter of the position back until after it.

3. The print and the gap¶

Q1 is the lowest-information print of the cycle. It is about 18% of revenue and 9% of operating income. The two print-dated gaps (May 21 and, by inference, Aug 26) came with the tax-season quarter and the full-year guide.
Gap risk isn't print-specific. Jan 14 and Feb 3 were heavy-volume breaks outside the usual earnings calendar (an inference, since the tools don't date earnings). That risk is in your 316–320 entry too, just at a slightly lower price.
Smaller starter. I'm cutting it from a third to a quarter. A 20% gap then costs 5% of full size, not 6.7%.

4. The stop, fixed¶

My 47% margin line was a bad stop. Fifty basis points on about $9.4B of Q3 revenue is roughly $47M of operating income, or about $0.13 of EPS, 0.7% of your $18.3. That is smaller than the unexplained −$18M Q4 net-income gap we both set aside. The thesis needs two things: FY27 GAAP EPS near or above $18, and a multiple that doesn't fall below about 16.5x. Your base case ($18.3) satisfies the first, so it's my fair-price case, not my stop. The thesis breaks on: - Q3 FY27 revenue growth below about 8%. - Operating margin below about 46%. - An FY27 EPS trajectory under about $18.

Exits are set per tranche, because a tranche bought at the daily SuperTrend can't use that same line as its stop:

Tranche	Size	Entry	Rule	Loss if stopped (of full size)
1	25%	~334 now	Exit on a daily close below 298.38	−2.7%
2	25%	316–320, only on a hold	Exit on a daily close below 298.38	−1.5%
3	25%	298–305	Judged against the September low: exit on a close below 261	−3.3% (from ~300)
4	25%	After the 10-K check and the Q1 print	Needs FCF/SBC/buyback reconciled and Q1 not breaking the thesis	n/a

If tranches 1–3 are all stopped in an orderly market, that is about −7.5% of full size. A gap through a stop costs more, as you said. The 10-K check now sits inside the plan. If SBC or the buyback split disappoints, tranche 4 isn't bought and tranche 1 gets reviewed.

5. What the remaining disagreement is worth¶

If it retraces to 320: your patience saves 4.5% on a quarter, about 1.1% of full size.
If it rallies to the 200 SMA without retracing: the starter earns about +9.9% on a quarter, about +2.5%.
If it gaps down 20%: the starter loses 5%.

I can't weight those scenarios, and neither can you. Three numbers that size mean the choice isn't worth the amount of debate we've given it, and it argues for a quarter-size starter, not zero. Your own plan also relies on a retrace that may not come: the trigger needs a close above 343.90 and then a pullback to 320, and a continuation straight to 367 leaves you flat.

Verdict¶

We agree on most of this. INTU is a high-quality business at a fair price of about 18.3x forward GAAP, with add levels at 316–320 and 298–305, and the 10-K work should happen now.

The bull case is that the P&L showed no AI damage through the year the narrative peaked. The business runs a 27.4% operating margin and 81% gross margin, with net debt around 0.5x EBITDA and a shrinking share count. At a 17–18x center it offers modest positive expectancy, with fatter right-tail outcomes (+21–27%) than I'd expect from a business with this margin structure.

What would make me bigger: - The 10-K reconciles FCF with SBC counted as a cost. - Q1 FY27 revenue growth is about 10% or better, a two-year stack near 30%, with margins holding. - A close above 343.90 with a hold at 319–320, which is your own trigger.

What would make me smaller or out: - A daily close below 298.38 (tranches 1–2), then below 261 (tranche 3). - Q3 FY27 growth below about 8% or margin below about 46%. - An SBC or buyback finding in the 10-K that changes the capital-return math.

I'd start with a quarter at $334.52, stage the rest, and keep a quarter back until the evidence arrives. Bull Analyst: # INTU Bull Final: Take the Gate, Keep the Starter

The bear's close is fair. I'm taking his sequencing point, which leaves a disagreement worth roughly 1% of a position.

What I concede¶

The center isn't pinned. The trailing multiple ran 15.4x to 22.4x on the same $16.44-16.46 of EPS. My +3-6% expected price return is inside one turn of error, so I can't claim a measurable edge. It's a judgment, and I'm sizing it as one.
I understated the Q4 net-income issue. The problem isn't the -$18M level. About $136M more operating income produced $18M less net income, so something absorbed roughly $100-150M, or 2-3% of FY26 net income. If that is a structural tax-rate or below-the-line change, FY27 EPS lands under $18. That belongs in the gate.
Sequence is not free optionality. The terms are unknown, so it is a cash use that competes with buybacks. It will also add GAAP amortization and acquired-employee stock compensation. I'm treating it as neutral until I've read the 10-K.
A Q1 print near 10% shows "no worse," not "better." That makes the late-November print asymmetric toward downside conviction.
The 10-K check goes before tranche 1. It's already filed and costs a day.

1. The gate, with pass/fail numbers set in advance¶

10-K item	Pass	If it fails
FCF net of SBC, stripped of one-time working-capital inflows	≥ ~$5.4B (6.0% of $89.4B, the bear's own threshold)	No tranche 1. The carry case fails.
Split of the $7.7B financing outflow	Mostly repurchases	If mostly debt paydown, the 3-4% share-count tailwind is overstated. Rebuild the EPS path.
Sequence consideration and GAAP drag	Under ~$1B (about a seventh of a year's stressed FCF) and under ~$0.10 of EPS	Recompute the $18.3 and the buyback capacity.
Q4 net-income offset (~$100-150M)	One-time item	If recurring, cut FY27 EPS by that amount.

The first row is closer than it looks. On the SEC-derived $8.66B, SBC would need to exceed ~$3.3B to fail. On the stressed $7.1B base, which assumes OCF/net income reverts to 1.60x, an SBC of 8% of revenue ($1.7B) is roughly a coin flip. The real question is how much of the 1.94x OCF/net income is recurring, and only the filing answers it. I can't run it from this data, so whoever sizes the trade should.

2. Why the starter still goes in after the gate¶

The print doesn't separate our plans as cleanly as the bear says. His 316-320 and 298-305 entries can fill before late November (the date is unconfirmed), so he carries print risk there too. Only the 343.90-retest path waits for the facts. The real difference is the price of the first quarter against a 320 entry: 4.5%, or about 1.1% of the full position.

The print isn't one-sided. The bear's own "change my mind" bar is Q1 growth of 12% or better, a two-year stack near 32%. Derived Q4 growth was +13.7%, so that bar is reachable. If a good print can move him, it can strengthen the thesis. Refusing every position ahead of every scheduled event would mean never owning INTU.

The thesis break is thin, and I'll say so. His base case is $18.3 and my line is $18. The cushion is about 115 bps of Q3 margin. A repeat of last year's 100 bps decline on top of his base costs about $0.26, leaving EPS near $18.04. That doesn't erase the cushion, but it is four cents from it. That is why this is a quarter-size position that I re-underwrite at each print.

The center uncertainty argues for staging, not zero. If tranches 1-3 all fill, the average cost is about $318-320, or 17.4-17.5x $18.3. That is the center I defended, not the 18x top of the range. The plan doesn't need the multiple to hold at today's level.

3. Final plan¶

Step	Size	Condition
Gate	n/a	The four 10-K items above pass
Tranche 1	25%	At market if the gate passes and the stock hasn't closed above 343.90 first. If it has, don't chase. Use the bear's retest of 316-320.
Tranche 2	25%	316-320, only on a hold
Tranche 3	25%	298-305; exit on a close below ~261
Tranche 4	25%	After the Q1 print: growth ~10% or better (two-year stack ~30%), margin holding near 46% or better, no new gate failures

Exit for tranches 1-2: A daily close below 298.38. That costs about 2.7% of full size on the starter in an orderly market and about 5% if a 20% gap goes through the stop.
Thesis break: Q3 FY27 revenue growth under ~8%, operating margin under ~46%, or an FY27 EPS path under ~$18.

Verdict¶

Neither of us disputes the facts. FY26 reported results show no AI damage: revenue +13.9%, operating margin 27.4%, 81% gross margin, net debt about 0.5x EBITDA and a shrinking share count. The stock halved while EPS grew 20%. At about 18x forward GAAP it is a fair price with modest positive skew. I can't prove an edge inside one turn of multiple, so I'm not claiming one.

My call is to accumulate INTU in gated, staged tranches. The first quarter goes in only if the 10-K check passes, and I wouldn't chase above 343.90. If the gate fails, the bear's patience wins and I'll say so.

Bigger: FCF net of SBC clears 6%, Q1 growth is ~10% or better with margins holding, or a close above 343.90 followed by a held 319-320 retest. Smaller or out: a gate failure, a daily close below 298.38 and then 261, or any of the Q3 FY27 break conditions.

Bear Researcher¶

Bear Analyst: # INTU Bear Case: A Great Business, but the Price Assumes the Hard Part Is Over

You asked which I'd take first, the Q3 deceleration or the AI thesis. They are the same argument, so I'll take them together. I'll also concede up front that the balance sheet is sound (D/E 0.44x, net debt about 0.5x EBITDA) and FY26 was a good year. My case isn't about distress. It's about a stock that has bounced 25% in 16 sessions and is priced as if growth durability were settled when the evidence says otherwise.

1. Q3 and AI are one story, and your "re-acceleration" is built on the wrong quarter¶

Where the profit growth came from. From your own figures, FY26 operating income rose about $961M. - Q3, which carries about 68% of annual profit, contributed only about $301M (+8.1%), less than its revenue growth of 10.4%. Operating margin there slipped from 48.0% to 47.0%. - The three off-season quarters, with about a third of profit, supplied roughly $660M, about 69% of the growth. Those gains came off tiny bases (+97%, +44%, +40%).

So the profit engine grew 8%, and the headline 19.5% came from cost discipline in quarters that barely matter. That kind of growth is hard to repeat, and Q1 FY27 faces a +97% operating income comp.

The Q4 "re-acceleration" is weak evidence. It is derived by subtraction, not reported. It is the smallest quarter (about $475M of operating income, 8% of the year). Its net income fell about 5% even as operating income rose about 40%, and you skipped that. Nobody has explained it.

The market already judged Q3. The stock fell 20% on May 21 (380.46 to 304.30) on 22.35M shares, 6 to 7 times normal volume. The tools don't date earnings, so the match to the print is my inference. But a market that treated Q3 as "one data point" doesn't reprice a stock 20% in a day. The Aug 26 gap, also on huge volume, lines up with the usual late-August report. The close was 368.20 on Aug 24, and an officer sold near $346 on Aug 27. That is consistent with a gap down, though again inferred. In both cases the stock fell after prints, so the late-November report is event risk, not a catalyst.

The consumer franchise. You dismissed the 2–3% TurboTax-related growth figure as an unverified user post, and it is. But it fits Q3's 10.4%, and it is cheap to check against the FY27 guidance. Also, Intuit launching free federal filing through Credit Karma Tax is hard to square with pricing power. If it cannibalizes TurboTax, you won't see it until the tax-season quarter, which is two-thirds of profit.

2. Your moat quote concedes my point¶

The StockTwits line you cite says AI platforms "will connect to deterministic systems like tax and accounting software." That makes Intuit the back-end utility. If the AI agent owns the customer relationship, it also owns pricing, cross-sell and the data. Deterministic logic isn't scarce when a model can call a rules engine. The Oct 20 posts about Gemini targeting small-business financial analysis go straight at QuickBooks.

"The stock fell 50%, so it's discounted" is circular. If the AI risk is to terminal value, no one knows what is priced in.

On Sequence, the deal terms are unknown. The "pop" came alongside ADBE, DOCU, MDB and MNDY (StockStory), so it is largely sector beta. Buying AI capability also signals a gap in what Intuit can build itself.

3. "Cheap" depends on the denominator¶

The multiple is back to 20.3x with no new fundamentals. At the June low (252.77) the stock was 15.4x FY26 EPS. It has re-rated about five turns in a bounce, and 49x was the anomaly, not the benchmark.
The 12.4x forward P/E is a mirage. Forward EPS of $26.94 is 64% above GAAP. You flagged that and then kept using PEG ~1.03, which rests on the same growth assumptions. Do the arithmetic yourself. If EPS grows 10–12% (revenue in the low double digits, plus buyback help), FY27 GAAP EPS is about $18.1–18.4. That puts INTU at about 18–18.5x forward GAAP earnings, not 12x. That is fair value for a business whose profit engine grew 8%, not a bargain.
FCF is overstated. Our feed says $6.35B and the SEC-derived figure says $8.66B, a $2.3B gap. OCF/net income rose from 1.60x in FY25 to 1.94x in FY26. If conversion simply reverts, OCF is about $1.5B lower. The tools don't break out stock-based compensation, which FCF treats as free.
The buyback looks worse in context. The $7.7B financing outflow is about 8.6% of today's market cap, yet diluted shares fell only about 2%. Some of that went to dividends or debt, but a large share was spent when the stock traded between roughly $380 and $670. Most Q4 buying near the lows is a plus, but the earlier $4.0B looks like money spent at nearly double today's price. EPS rose 20.4% against net income up 18.0%, and equity fell 3.6%.

4. The tape doesn't agree¶

The technical report ranks weekly over monthly over daily. You led with the daily signal, which is the lowest tier. Weekly SuperTrend is DOWN (stop 390.56, 16.8% above), monthly is DOWN, and the 50 SMA sits below the 200 SMA.

This bounce has failed before. From 252.77 (June 25) the stock rallied 45.7% to 368.20 (Aug 24). It then fell 27.5% to 266.79 in five weeks. The current bounce is smaller (+25%).

Other signs of exhaustion: - Highs are lower: 371.25 in August, then 340.72 on Sep 14 and 341.79 on Oct 20. Both recent highs stopped under the 343.90 upper band, and the 334.52 close is below the Sep 14 closing high of 337.58. - The daily TD-9 sell setup is complete, and the MACD histogram peaked at 6.41 on Oct 20 and has ticked down. RSI peaked at 65.49. - ADX at 31.31 isn't bullish confirmation. It read 34.7 on Sep 29 during the selloff. ADX measures strength, not direction. - The last bar is probably partial (951,640 shares versus 2.5M–4.5M typical), so the RSI, MACD and ADX figures you quoted are provisional.

Risk/reward from here:

Level	Distance	Why it matters
343.90	+2.8%	Upper Bollinger, double top zone
367.51	+9.9%	200 SMA
390.56	+16.8%	Weekly regime flip
319–320	−4.4% to −4.6%	10 EMA / 50 SMA
298.38	−10.8%	Daily SuperTrend flips DOWN
266.79	−20.2%	September low

ATR is 12.10, or 3.6% of price, so one ordinary day's range exceeds the distance to the first resistance. The first pullback target is about 4.5% away, and the real support is about 11% away.

5. Macro, sentiment and insiders¶

Rates: You discounted the 78% December-hike market for its thin $1M volume. The 97% "no cuts in 2026" market has about $9M behind it, and it points the same way. I concede the 8% recession odds, so a demand shock is not my case. But a stagnant-to-tightening rate path with an unresolved terminal-value debate means the multiple, not earnings, is the exposed variable. Credit Karma also carries lending-cycle sensitivity.
Sentiment: The "12 bullish, 0 bearish" count comes from about 9 authors, and the language is "meme coin move." Retail users name a $340 trigger and a $400 exit, so they are crowded at the same resistance. The Zacks "26% upside" is a sell-side target, not independent confirmation.
Insiders: Scott Cook sold about $530M across 2025, including $327.5M in December at $632–678. The CEO sold $26.65M at about $650 on Jan 7, and the stock closed at 559.75 a week later, about 14% lower, on a heavy-volume break. I'm not claiming anyone knew anything. But the one discretionary buy, $542K by a director, is roughly one-thousandth of Cook's sales. No CEO or CFO has bought a share at a price half the old level, and a director sold near the lows in June at $262–298.

Verdict¶

INTU is a high-quality franchise whose 2025 price was a bubble, and its 2026 price is a rally inside an unresolved downtrend. Your thesis rests on three numbers you flagged yourself as doubtful: the 12.4x forward multiple, the $6.35B vs $8.66B FCF gap, and the derived Q4. The chart evidence ranks lowest in the hierarchy, and the last 45% bounce failed.

What would change my mind: - A weekly close above 390.56. - Q3 FY27 revenue growth back above 13% with margin holding in the tax-season quarter. - FCF reconciled to the 10-K with SBC counted as a cost. - FY27 guidance that clears the 2–3% consumer-tax worry.

Until then, I wouldn't chase this. Better entries are on a pullback to the 298–300 zone, or after the evidence arrives. Bear Analyst: # INTU Bear Closing: We Agree on the Business, Not on What $334.52 Pays For

You conceded a lot, so I'll do the same before the three disagreements that remain.

What I concede¶

FCF arithmetic: Reverting to 1.60x OCF/net income gives about $7.1B of FCF, an 8.0% yield, which beats the $6.35B figure. My haircut didn't hurt your number, so I'm dropping it. The SBC issue below is what's left of my FCF objection.
The partial bar: I cited the MACD tick from 6.41 to 6.21 while also flagging that bar as incomplete. That's withdrawn. The daily TD-9 count doesn't depend on that bar, but it's a watch item, not a timing signal.
The double top: The neckline is about 21% away, so it isn't a signal. I'll call it a failed test of 343.90 instead.
Derived Q4: It's arithmetic, and the −$18M gap doesn't move valuation. My point was only that Q4 is about 8% of profit.
Share count and AI in the P&L: Some of the 267M vs 277M gap is basic vs diluted, but I accept a real 2–3% tailwind. I also accept that FY26 reported numbers show no AI damage so far.

1. The EPS bridge isn't the fight. The multiple is.¶

Your $18.5–18.9 is a fair "Q3 holds near 10%" case, and my $18.1–18.4 is the "high single digits" case. They differ by about 3%. At $334.52 INTU trades at roughly 18x either one. EPS growth gets a holder about 10–12% a year. Each turn of multiple moves the price about 6%.

The stock went from 16.2x trailing at the September low (266.79) to 20.3x now. That's about four turns in 16 sessions with no new earnings, in a rally shared with ADBE, DOCU, MDB and MNDY.

Forward multiple in 12 months	Price on ~$20.3 forward EPS*	vs. $334.52
15x (about June's low multiple)	~$305	−9%
18x (today's forward)	~$366	+9%
20x (today's trailing)	~$406	+21%

*My assumption: $18.3 FY27 EPS grown about 11%. Dividends add 1.65%.

Three turns of compression wipes out a full year of EPS growth. You called 49x an anomaly, so the June 15x was the market pricing the AI and deceleration uncertainty. Nothing has resolved that uncertainty since.

2. A lagging P&L can't clear a forward risk¶

AI disruption is a claim about terminal value. Reported FY26 numbers are backward-looking, so they would show damage only after customers had already moved. The forward-looking data points are Q3's 10.4% and the unverified 2–3% consumer-tax guide.

Your FY23 and FY24 comparison is a convenient baseline. The direction is FY25 +15.6%, then FY26 +13.9%, then +10.4% in the quarter that matters most.

Your own kill switch is Q3 FY27 growth below about 9%, or margin falling again from 47%. Q3 FY26 grew 10.4% and margin fell about 100 bps. A repeat of last year trips the margin leg. A further 1.4 points of slowdown trips the growth leg. My base case sits about a point from your kill switch.

The next full test is six months away. The late-November print can't raise conviction on the tax season, but it can lower it, since Q1 laps +97% operating income growth. You said I can't prove the moat breaks, but the buyer paying 18x for durability carries the burden.

3. The carry isn't 7–8%¶

Cash: Only the 1.65% dividend is contractual cash to holders.
FCF yield: The tools don't report SBC. Illustratively, if it runs 8–10% of revenue (my assumption, not our data), that's about $1.7–2.1B. That takes the $7.1B base down to a 5.6–6.0% FCF yield, so check the 10-K.
Buybacks: The 5–6% retirement figure is gross of SBC issuance, and it's discretionary. "Twice the shares per dollar versus $650" anchors on a price we both called a bubble. A buyback creates value only below intrinsic value, which is the question in dispute.

4. Your plan contradicts itself¶

You add at 298–301 and reduce on a close below 298.38, which is the same price.
You call the technical case broken near 252, about 25% below here. Your target is the weekly flip, 16.8% above. That's a stop wider than the target.
A starter at $334.52 has +2.8% to first resistance and −4.5% to first support.

What Q3 FY27 looks like in my model: Revenue is +9–10% with margin around 46.5–47%. That gives operating income of about $4.35–4.4B and full-year EPS of about $18.3. At 298–300 you pay about 16.3x, roughly one turn above June's low multiple. The 298–301 zone also stacks the daily SuperTrend, the mid-Bollinger band and the October lows, so risk is defined, with the September low about 11–13% below. It's not a bargain, but it's a priced risk.

If it never pulls back: I've lost a trade, not capital. I'd also take a starter on a daily close above 343.90 followed by a retest of 319–320 that holds, because that would be evidence of a higher high. The 390.56 weekly flip was my regime-change trigger, not my entry rule, so your 17%-more table argues against a plan I didn't propose. The 10-K reconciliation of FCF, SBC and the buyback split costs nothing to wait for.

5. Brief notes¶

Rates: I'll drop the thin-volume 78% hike market. The 97% no-cuts market is enough to say policy offers no multiple tailwind.
Insiders: At these sizes it's noise either way.

Verdict¶

INTU is a good business. At $334.52 the price assumes the multiple holds near 18x while the key quarter decelerates. The advertised carry is really 1.65% plus buybacks at management's discretion. Two inputs aren't in the price yet: the 10-K reconciliation (FCF, SBC, buyback split) and the late-November print and guide.

I wouldn't add at $334.52. I'd rather own it at 298–301 with a defined stop, or after those two inputs arrive. Bear Analyst: # INTU Bear Final: We Agree on the Business and the Add Levels, and Differ on the First Third

The gap between us is now one decision: whether to own a third of the position at $334.52 or at about $320. Here is what I'm giving up, then where I still disagree.

What I concede¶

The 10-K is already filed. The FCF, SBC and buyback split are diligence we can do today, not a future catalyst. I was wrong to frame them as inputs we're waiting for.
The Credit Karma Tax launch postdates Q3 FY26. It can't explain that quarter. It is an FY27 variable.
The break-even arithmetic is right. On about $20.3 of forward EPS, 16.5x is flat.
The SBC figure was my illustration, not data. I'll accept 5.5–6% as the carry range with that caveat.
Your tranche plan is now coherent at 316–320 and 298–301, which are my levels too.

1. "Positive skew" depends on weights neither of us has¶

Your table is a grid, not a distribution. Weight the five rows equally and you get (−15 −9 +0 +9 +21) ÷ 5 ≈ +1.2%, or about 3% with the dividend. The "low-teens" return is the return conditional on the 18x row, not the expected value.

Making 18x the base case requires an explanation for the move from 16.2x trailing at 266.79 to 20.3x now, about four turns in 16 sessions. FY27 EPS hasn't changed in that time. What changed: - The Sequence deal, with unknown terms and a pop shared with ADBE, DOCU, MDB and MNDY. - The international Intuit Intelligence rollout and the Aprio partnership, which are headline-level. - A sector bounce.

None of these moves an EPS number I can model, so the base case rests on sentiment holding. On carry, the forward 5.5% earnings yield is a forecast. Trailing it is 4.9% ($16.46 ÷ $334.52). FRED failed, so we have no verified Treasury yield to compare either against, and "pays me to be early" is untested.

2. Your leading indicator is a blend that hides the direction¶

Your +16.4% off-season figure averages three quarters that are not alike:

Quarter	Revenue growth
Q1	+18.3%
Q2	+17.4%
Q3	+10.4%
Q4 (derived)	~+13.7%

First half growth was about +17.8% and second half about +11.5%, and year-over-year comparisons neutralize seasonality. The freshest off-season print, Q4, is the weakest of the three. Q1 FY27 laps +18.3%, the toughest comp of the year. I can't tie the H1-to-H2 slowdown to a cause, and neither can you.

The idea that disintermediation would show up first in the off-season is your assumption, not data. Subscription revenue renews slowly. If consumers substitute AI for tax prep, that hits Q3, which is where the crack is. You said our data doesn't identify its cause. An unexplained slowdown in the biggest quarter, with a free-filing variable arriving before the next tax season, is not a resolved risk.

3. The print is not "just sentiment"¶

You said a 20% Q1 operating-income miss is under 2% of annual operating income, so it's a sizing issue. But you agreed the multiple is the exposed variable, and each turn is about 6%. The one scheduled event that sets the multiple can't be both. The May 21 move of −20% wasn't proportional to any quarter's share of profit.

The risk plan has two problems: - Gaps. A close-based stop at 298.38 doesn't protect against a gap. A 20% gap from 334.52 lands near $268, through the stop and close to the September low. On a third of the position that is about −6.7% of full size, nearly double the −3.6% in your plan. - Ambiguity. The table says a close below 298.38 reduces to starter size, and the starter isn't exited until about 261, which is −22%. Your text calls 298.38 a "stop-out." It can't be both.

4. Your fundamental stop is my base case¶

You break the thesis at Q3 FY27 growth below about 9% or operating margin below 47%. My base case is +9–10% growth with margin of 46.5–47%. That puts me at or just across your line on margin. A trade whose exit condition is the other side's base case isn't skewed in your favor. The only evidence we have on Q3 is 10.4% growth, margin down about 100 bps, and no explanation.

5. The actual disagreement: the first third¶

You said my retest trigger means paying 18.8x or more. That's wrong. My trigger is a close above 343.90, then a hold at 319–320. I'd be buying at about $320, or 17.5x your $18.3, after a higher high has cured the lower-highs problem. That's a better multiple on a better chart than your starter at 18.3x. If the stock never retests, I lose a trade and keep my capital. I accept that.

The starter's cost is a roughly 4.5% worse entry than 320. That is more than one ATR (12.10, 3.6% of price). The 340–344 zone has been tested twice without a close above it. The daily TD-9 sell setup is complete, and a print is about a month away. The 10-K work costs nothing and takes a day. Do it before buying, not after.

Verdict¶

INTU is a high-quality franchise at a fair-to-full price. It has re-rated about four turns on sentiment while growth decelerated in the biggest quarter for unexplained reasons. A print is coming that can lower conviction before it can raise it.

My plan: - Do the 10-K reconciliation now. - Buy 316–320 if it holds, or 298–301 with a defined exit that accounts for gap risk. - Or buy the retest after a close above 343.90.

What would change my mind: - Q1 FY27 revenue growth at or above Q4's derived ~13.7% against the +18.3% comp, which would show the deceleration has stopped. The tools don't confirm the report date. - FCF reconciled with SBC counted as a cost. - A weekly close above 390.56.

I wouldn't pay $334.52 for the first third. Bear Analyst: # INTU Bear Final: Fair Price, Free Diligence, Scheduled Event Risk

We now agree on the quality of the business, on forward GAAP P/E near 18x, on the add zones (316-320 on a hold, 298-305), and that the 10-K work should happen now. The one live question is whether the first quarter-sized tranche goes in at $334.52 or after the facts arrive. First, what I'm giving up.

What I concede¶

The grid. The equal-weighted +1.2% was my arbitrary choice. A symmetric grid's mean is its center, so the real question is where the center belongs.
The two-year stack. Q1 FY27 growth of about 10% against +18.3% is roughly +30% over two years. My 13.7% bar was too high as a test of "no further deterioration," so I'm retiring it.
Q1's weight. It is about 9% of operating income. It is a multiple event, not an earnings event.
The plan. A quarter-sized starter with per-tranche rules is coherent and fixes what I objected to.

1. Your center rests on a number that can't be pinned down¶

You anchor the center at 17-17.5x using the 50-day average ($321) and the midpoint of the four-month closing range ($310). Your own data undercuts that. Trailing EPS has been $16.44-16.46 since the Q3 print, and the trailing multiple on that same base ran from 15.4x to 22.4x. That is seven turns, about ±18% around the middle, with no change in earnings. A 50-day average and a range midpoint describe where sentiment oscillated. They don't measure intrinsic value.

Two consequences follow: - The edge is the same size as the error. One turn is about 6%. Your whole expected price return (+3% to +6%) is one turn of uncertainty in where the center sits. A 16.5x center gives 0% and an 18x center gives +9%, and nothing in the data picks between them. - The −15% row isn't a tail. 14x forward is what the stock printed on June 25 (252.77 ÷ $18.3 = 13.8x), four months ago.

So you are being paid a 3-6 point center, or 5-8% with the dividend, for a grid spanning 36 points and a 3.6% daily ATR. I can't verify the risk-free comparison because FRED failed, so I won't claim the edge is negative. But nobody can show it is positive, and thin edge plus fat dispersion is the case for patience.

2. Free diligence should come before tranche 1¶

You agree SBC may take the carry from about 8% to 5.6-6.0%. My SBC figure was an illustration, not data. Even so, that is a haircut of roughly a quarter to a third on your headline metric. The 10-K is already filed, so reconciling FCF, SBC, the dividend/buyback/debt split and the Q4 net-income gap takes a day.

Your plan buys tranche 1 first and gates tranche 4 on the check. Then, if the check disappoints, tranche 1 "gets reviewed." That pays for an option to unwind at a loss.

Sequence belongs in the same check. You carry it as free optionality outside EPS, but the terms are unknown. It is a cash use that competes with your "$5B+ for repurchases." It also adds GAAP amortization and acquired-employee stock compensation to the $18.3. The Mailchimp step-up in FY22 assets is the precedent in our data, and goodwill and intangibles aren't itemized. Read them before assuming the deal is upside.

3. Your thesis break is close to my base case¶

You set the break at FY27 GAAP EPS under about $18, and my base case is $18.3. By your own sensitivity (about $0.13 per 50 bps of Q3 margin), that $0.30 gap is about 115 bps of Q3 margin below my base. Q3 FY26 gave up about 100 bps. That is a 1.6% EPS cushion, which one repeat of last year's margin move would erase.

Your "make me bigger" bar has a similar problem. Q1 growth of about 10% is Q3 FY26's own 10.4%, the print that preceded a 20% one-day drop. The two-year stack is fair, but it means the print can show "no worse," not "better." That makes the scheduled event asymmetric. It can break the thesis, and by your own bar it can't strengthen it.

The history doesn't help the starter either. The May 21 (-20%) and, by inference, Aug 26 gaps both came on prints. You argued gap risk isn't print-specific because Jan 14 and Feb 3 also broke on heavy volume. I agree, and that is why a close-based stop at 298.38 is only partial protection. A 20% gap costs the starter 5% of full size, not 2.7%.

4. What waiting actually costs¶

By your own scenarios: - A retrace to 320 saves about 1.1% of full size. - A straight run to the 200 SMA earns about 2.5%. - A 20% gap loses 5%.

Take your 5-8% expected return, which I think is generous, and apply it to five weeks until the print (unconfirmed, likely late November). Waiting costs about 0.5-0.8% of the starter's value, or roughly 0.1-0.2% of the full position. That buys the 10-K answer and a look at the one event that can only hurt the thesis. A fair price creates no urgency.

The starter's best case is continuation through the 340-344 zone, which has stopped price twice without a close above it. That is a chart argument, and the weekly and monthly trends remain down. The last bounce of this size ran +45.7% and then lost 27.5% in five weeks.

Verdict¶

INTU is a high-quality franchise at a fair-to-full price. It has re-rated about four turns off the September low on sector beta and headlines, while the biggest quarter decelerated for reasons neither of us can explain. We agree on the levels. The gap between us is the first quarter of the position.

My plan: 1. Do the 10-K reconciliation now: FCF net of SBC, the buyback/dividend/debt split, Sequence terms, goodwill and the Q4 net-income gap. 2. Buy at 316-320 only if it holds. Otherwise buy 298-305, sized for a gap rather than a close. 3. Or buy the retest after a close above 343.90 that holds 319-320.

What would change my mind: - FCF net of SBC is still above about 6%. - Q1 FY27 growth is 12% or better (a two-year stack near 32%) with margin holding. - Sequence terms are small relative to FCF. - A weekly close above 390.56.

I wouldn't pay $334.52 for the first quarter. I'd rather pay for it with the facts in hand, even if that costs me half a point of upside. Bear Analyst: # INTU Bear Close: The Gate Is Right, but It Doesn't Test the Contested Variable

You took the sequencing point, so the gap is now small. I'll say what you got right, then what the gated plan still leaves out.

What I concede¶

Print risk. My 316-320 and 298-305 entries can fill before late November, so I carry event risk too. The difference is the price at which I carry it, not whether I carry it. I'm not refusing positions ahead of every scheduled event.
A good print can move me. Derived Q4 growth was +13.7%, so my 12% Q1 bar is reachable.
The gate. Pass/fail numbers set in advance are a real improvement, and so are per-tranche stops.
The cushion. A repeat of last year's 100 bps margin decline on my base lands near $18.04. I accept your arithmetic.

1. The gate tests the numbers we already agree on¶

On the data we have, most rows should pass. The SEC-derived $8.66B of FCF needs SBC above about $3.3B to fail. The $1.64B Q4 equity decline fits repurchases. Those checks confirm cash conversion, which neither of us has seriously attacked since the earlier concessions.

The contested question is why Q3 slowed, and it isn't in the gate. We have each said we can't explain it, and we've said the tools lack segment splits. The filings aren't limited by our tools. If Intuit still reports consumer, small-business, Credit Karma and ProTax lines the way it historically has (I can't verify that from here), the April-quarter 10-Q and the 10-K show where the slowdown sat. I'd add a fifth row:

Row	Pass	Fail
Q3 segment growth	Slowdown concentrated in consumer tax, with small-business growth holding near its H1 pace	Small-business or QuickBooks growth also decelerated, which is the AI-disintermediation signature

It costs the same day as the other rows and addresses the question the whole debate turns on. Until it's answered, 18x forward is a price for a slowdown nobody has located.

2. The Q4 row is a thesis test, not a footnote¶

Your rule says that if the roughly $100-150M Q4 net-income offset is recurring, you cut FY27 EPS by that amount. On about 267M shares that is $0.37-0.56. Taking that from $18.3 gives $17.74-17.93, under your own $18 break line before Q3 FY27 does anything. If the item began in Q4, FY26 carries only one quarter of it, so the FY27 step-down could be larger than "that amount." I can't tell which from this data, and it could equally be a one-time item.

This is why my $18.3 isn't a floor. That row can fail on facts already filed, so it belongs first in the gate.

3. Tranche 1 is a chart trade with a poor chart payoff¶

You stop tranches 1-2 on a chart level, a daily close below 298.38. Judged by the chart, the payoff to the 200 SMA (367.51) looks like this:

Entry	Distance to stop	Distance to 200 SMA	Reward:risk
334.52	-10.8%	+9.9%	0.9:1
320	-6.8%	+14.8%	2.2:1
318	-6.2%	+15.6%	2.5:1

The entry rule has another oddity. It buys at market under 343.90, a level price has failed at twice, and refuses to buy above it. If the stock closes above 343.90, your plan also waits for a 316-320 retest, which is my plan. The starter earns its keep only in a narrow path: price drifts up, stays under resistance, and never retraces. Your own numbers put the stakes at about +1.1% of full size if it retraces to 320 and -5% if a 20% gap hits the stop. Weekly and monthly trends are still down, and the daily TD-9 sell setup is complete.

One more tension. You call Q1 the lowest-information print, yet you gate tranche 4 on it. You also agreed that ~10% growth only shows "no worse." If the upside from the print is that limited and the downside isn't, that argues for buying cheaper, not sooner.

Verdict¶

INTU is a high-quality franchise at a fair price, and our whole disagreement is worth about 1% of a position. My plan:

Run the 10-K gate with two changes: put the Q4 offset first, and add the Q3 segment row.
Buy 316-320 only on a hold, or 298-305 sized for a gap rather than a close.
Alternatively, buy the retest after a close above 343.90 that holds 319-320.
Don't buy under resistance at $334.52 for 0.9:1.

If the stock runs to 367 without a pullback, I'm flat and I give up roughly 2.5% on a quarter-sized starter. I accept that.

What would change my mind: - The Q4 offset proves one-time. - Segment data puts the Q3 slowdown in consumer tax, with small business holding. - FCF net of SBC is at least 6%, and Sequence terms are small relative to FCF. - Q1 FY27 growth is 12% or better with margins holding. - A weekly close above 390.56.

If those arrive, I'd pay up.

Research Manager¶

Recommendation: Overweight

Rationale: By the end, the two of them had argued themselves into nearly the same place, and that settles the direction. Both accept the FY26 facts from the filings: revenue up 13.9% to $21.45B, operating margin up to 27.4%, 81% gross margin, EPS up 20.4% to $16.46, OCF up 42%, net debt around 0.5x EBITDA, and a shrinking share count. The stock still halved, so this is a valuation reset, not a broken business. Both also settled on about 18x forward GAAP (FY27 EPS roughly $18.3–18.9) as a fair price with modest positive expectancy. Neither argued for trimming or exiting. The bear's own plan is to buy at 316–320 and 298–305. That puts the stance at constructive, and sizing is the real question. The bear won most of the execution arguments, and I'm adopting them. First, the 12.4x forward P/E, the 7–8% carry and PEG near 1.0 did not survive scrutiny. Carry is closer to 5.5–6% once you allow for SBC, which our tools don't report. The expected-return center (about 17–18x) sits inside one turn of multiple error. Second, Q3, the tax-season quarter that carries about 68% of profit, slowed to 10.4% with roughly 100 bps of margin loss, and neither side can explain why. Third, the roughly $100–150M Q4 offset between operating income and net income could, if it recurs, push FY27 EPS to $17.74–17.93. That is below the bull's own $18 break line before FY27 even plays out. Fourth, at $334.52 the chart payoff is poor. It is about 0.9:1 to the 200 SMA (367.51) against the 298.38 daily SuperTrend stop. Price sits under the 340–344 zone, which has capped it twice. Weekly and monthly SuperTrends are down, the daily TD-9 sell setup is complete, and the last similar bounce (+45.7%) gave back 27.5%. The bull's best points were these: there is no AI damage in the reported numbers, a staged plan's average cost lands at the defensible 17.4–17.5x center, and the late-November Q1 print can also raise conviction, since the bear's 12% bar is reachable against a derived Q4 of +13.7%. Net, this is a constructive, accumulate-on-terms call, not a chase. That is Overweight, executed with the bear's sequencing: do the free diligence first, then buy at the agreed add zones rather than at $334.52. Several inputs are missing from our data: segment splits, SBC, the buyback/dividend/debt split of the $7.7B financing outflow, Sequence deal terms, a confirmed Q1 report date, and Treasury yields (FRED failed). The last daily bar was also partial. That is why sizing stays staged and capped ahead of the print.

Strategic Actions: Target: build INTU to about 1.0x a standard allocation in four 25% tranches, with room to go to about 1.25x only after the Q1 FY27 print confirms. Holders already at standard weight should hold, not trim, and add only under the rules below. Step 0, the gate, comes before any purchase. Use the already-filed 10-K and the April-quarter 10-Q. (a) Q4 net-income offset first: if the roughly $100–150M is recurring and the FY27 EPS path falls below about $18, stop adding and treat the call as Hold. (b) Q3 segment growth: if the slowdown sits mainly in consumer tax and small-business/QuickBooks held near its H1 pace, pass. If small business also decelerated, which is the AI-disintermediation signature, cap the position at 50% of target. © FCF net of SBC, excluding one-time working-capital inflows, must be at least about $5.4B (6% of the roughly $89.4B market cap). (d) The $7.7B financing outflow should be mostly repurchases; if it was mostly debt paydown, rebuild the EPS path. (e) Sequence consideration under about $1B and GAAP drag under about $0.10 of EPS. Step 1: do not buy at market at $334.52. Do not chase strength under or through 340–344. Step 2, tranche A (25%): buy at 316–320 (the 10 EMA / 50 SMA cluster) only on a daily hold of that zone. Alternatively, after a daily close above 343.90, buy a retest of 319–320 that holds. Stop: a daily close below 298.38. Step 3, tranche B (25%): buy at 298–305, sized for a 20% gap rather than a close-based stop. Stop: a daily close below about 261, the September-low higher-low failure. Keep pre-print exposure at no more than 50% of target. Step 4, tranche C (25%): add after the Q1 FY27 print (likely late November; our tools don't confirm the date) if revenue growth is about 10% or better, a roughly 30% two-year stack, with operating margin holding and no new gate failures. Step 5, tranche D (25%, and up to the 1.25x overweight): add if Q1 growth is 12% or better with margins intact, or on a weekly close above 390.56. If the stock runs to the 200 SMA (about 367.5) without a pullback, accept being underexposed and reassess at the print rather than chasing. Thesis-break exits apply to the whole position: Q3 FY27 revenue growth below about 8%, operating margin below about 46%, or an FY27 GAAP EPS path below about $18. On any of these, reduce to below standard weight or exit. Position risk if tranches A and B both stop out in an orderly market is roughly 3–5% of full size. Gap risk through stops can roughly double that, which is why pre-print exposure stays capped.

III. Trading Team Plan¶

Trader¶

Action: Buy

Reasoning: The research plan is Overweight, which maps to Buy. The business is intact (FY26 revenue +13.9%, operating margin 27.4%, EPS +20.4%), and both sides agree on a fair value near 18x forward GAAP EPS. The technicals argue against buying at market: the weekly and monthly SuperTrends are down, the daily TD-9 sell setup is complete, price sits just under the 340-344 zone that has capped it twice, and the payoff to the 200 SMA (367.51) against the 298.38 daily SuperTrend is only about 0.9:1. So this is a staged accumulation, not a chase. Tranche A goes in on a daily hold of the 10 EMA / 50 SMA cluster at 316-320, and only after the plan's Step 0 diligence gate passes (Q4 net-income offset, Q3 segment growth, FCF net of SBC). Tranche B comes at 298-305. Later tranches wait for the Q1 FY27 print, whose date our data does not confirm. SBC, segment splits, the financing-outflow split and Treasury yields are also missing, and the last daily bar is probably partial.

Entry Price: 318.0

Stop Loss: 298.38

Position Sizing: Target is about 1.0x a standard allocation, built in four 25% tranches. Portfolio context is not provided, so apply this to your own book: holders already at standard weight should hold and add only under these rules. Tranche A is 25% of target at 316-320, on a daily hold of that zone. Tranche B is 25% at 298-305, sized for a gap risk of about 20% rather than a close-based stop. Keep exposure before the Q1 FY27 print at no more than 50% of target. Add tranche C after the print if revenue growth is about 10% or better with margins holding. Add tranche D, up to 1.25x, if growth is 12% or better or on a weekly close above 390.56. Do not buy at market at 334.52 or chase strength through 340-344. If the Step 0 gate fails on the Q4 offset (FY27 EPS path below about $18), stop adding and treat the call as Hold.

FINAL TRANSACTION PROPOSAL: BUY

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: Let me open by saying what this trade is. It isn't a bet on a perfect chart. It's a bet that a high-quality business has been priced for a worse outcome than the numbers show, with entries structured so we don't pay for the privilege of being early.

Start with the business. FY26 revenue grew 13.9%, operating income 19.5%, and EPS 20.4%, with operating margin at a multi-year high of 27.4%. Operating cash flow was $8.8B, and even on the conservative $6.35B free cash flow figure, that's a 7% yield. The stock is at about 20x trailing GAAP earnings, down roughly 51% from its high. Management is acting like it knows something too. Financing outflows were $7.7B, with roughly $3.7B in the July quarter alone. That's about 4% of today's market cap in one quarter, and a director put $542K of his own money in at around $310. Scott Cook sold $327M at roughly double today's price and has been quiet all year. I'll concede the buyback split isn't in the data, so some of that outflow could be debt paydown. But the direction is clear.

Now the objections I expect. The conservative will say the weekly and monthly SuperTrends are down, the 200 SMA is overhead, the daily TD-9 is complete, and it's the worst year since 1996. All true, and the plan already respects it, which is why it says don't buy at 334.52 and don't chase 340-344. But a weekly SuperTrend flip at 390.56 means waiting for a price 17% higher. Trend filters are built to be late. If you require the weekly to confirm, you buy after the move and call it prudence. The tape also isn't a dead-cat bounce. The September low of 266.79 is above the June low of 252.77. Volume is confirming, with OBV rising since September 29. ADX went from under 11 to 31 in about two weeks. That's a regime shift, not noise.

The risk/reward objection is the one I like best. From 334.52, the 0.9:1 payoff to the 200 SMA against the daily stop is bad. Nobody disputes that, and it's why the plan doesn't buy there. From a 318 entry, it's about 49.5 points to the 200 SMA against about 19.6 to the stop, roughly 2.5:1. To the weekly stop at 390.56, it's about 3.7:1. The entry price changes the trade. And the dip isn't a heroic ask. 318 is about 1.4 ATRs below the current price, with ATR at 12.10. That's a couple of ordinary sessions, so patience is cheap.

The neutral analyst will say the data is messy, and it is. Forward EPS of $26.94 is almost certainly non-GAAP, so the 12.4x forward multiple is flattered. I'm not going to defend it. The plan uses 18x forward GAAP instead. If FY27 GAAP EPS grows 15%, that's about $18.90 and a value near $341. If it matches FY26's 20% growth, it's about $19.80 and roughly $356. At the plan's own $18 gate, you're at about $324, so you wouldn't be overpaying even in the failure case. That gate is the discipline. If the Q4 net-income offset and Q3 segment growth don't check out, we stop adding.

The Q3 slowdown to 10.4% is the real bear point. But it sits next to 18% and 17% growth in the first two quarters and about 14% in the derived fourth, while margins and cash flow kept expanding. The market is pricing a permanent break in the biggest quarter. I'd rather own the possibility that it's a trough in growth, at a price that already assumes the worst, than wait for proof and pay for it.

On macro, a 78% Polymarket probability of a December hike is a headwind for long-duration software. It's also thin, about $1M of volume, and unverified because FRED returned nothing. But the stock rallied 25% into that backdrop. Recession odds are only 8%, beta is about 1.0, and a 7-10% FCF yield is a real cushion against multiple pressure. I'll grant that Credit Karma is rate and credit sensitive. That's a reason for sizing, not for sitting out.

Gap risk is the legitimate fear, since May 21 was a 20% one-day drop on 22M shares. The answer is sizing. Pre-print exposure is capped at 50% of target, so even a repeat 20% gap costs about 10% of one standard position. We add only after seeing the Q1 FY27 numbers, and we never add through resistance. That's how you take an asymmetric bet without betting the book.

Sentiment is a modest tailwind, and I won't oversell it. The Sequence deal and the Intuit Intelligence rollout support the AI-as-growth story, and the Zacks headline implies targets in the low $420s. Zero bearish StockTwits tags from about nine authors is thin, and "meme coin move" language is itself a warning against chasing. That's another reason the plan buys pullbacks rather than strength.

The cost of caution here isn't zero. If INTU is a business that earns $8B+ in cash and is priced like it's broken, the people who wait for the weekly SuperTrend, the confirmed print, and the Fed to cooperate will all be buying at much better-looking charts and much worse prices. I back the Buy, staged as written. Aggressive Analyst: The neutral analyst is right that we're arguing over a label and one tranche. Nobody is buying 334.52. Once you drop the pieces that are broken, the conservative's fallback and my plan are the same action: a 25% starter at 316-320 on a daily hold, after the diligence gate, ahead of the print. So I'll give ground where you've earned it and fight for what's left.

Tranche B as written doesn't survive. If a close under 298.38 means the bounce failed, I can't also be adding at 298-305. Drop it before the print. The Tranche C trigger at about 10% growth is also wrong, and the conservative is right that 10% is the quarter that broke the stock. I'd set C at low-teens revenue growth, margins holding, and guidance that supports roughly $18.50 to $19 of GAAP EPS. I overreached on ADX, which read 34.7 at the bottom of the decline and has no direction. The director's $542K is a footnote, a tiebreaker rather than a pillar. And the 7% FCF yield is before stock comp, so I'll lean on the 4.9% GAAP earnings yield, which is already after it. None of that changes the direction.

On the stop versus the 20% gap, the two do different jobs. The stop says when the thesis is wrong. The size says what it costs if you're wrong at the worst moment. Every stop on every stock has gap risk. If you treat the stress case as the typical payoff, no earnings-exposed position passes. The 0.8:1 figure is what the trade looks like if May 21 repeats, and gaps run both ways. This stock rose 25% in sixteen sessions without an earnings print that I can see. With B gone, a 25% starter costs about 1.5% of a standard position if the stop works and about 5% if the worst gap repeats exactly. That's the price of the option.

The neutral's EPS math was the best work in this debate, but it treats the buyback as already spent. FY26 weighted diluted shares were about 277M, and market cap over price implies about 267M today. Some of that gap is basic versus diluted, but $3.7B of repurchases in one quarter means FY27 starts a few percent below the FY26 average. Flat net income on a 3% smaller count is about $17. Net income growth of 11%, well under the 18% FY26 delivered, gets you near $18.85. So $18.90 needs earnings to grow at about two-thirds of last year's pace, not the off-season quarters up 23%. The flat derived Q4 EPS alongside operating income up 40% is a below-the-line anomaly, which is what Step 0 exists to explain. It isn't evidence the operating engine is fading.

It's also true that base-case value of $341 sits at first resistance, but that's a static snapshot. Roll it forward a year. If EPS grows mid-teens and the market holds the plan's own 18x, you land around $370 to $390, which is the 200 SMA and the weekly stop. The 200 SMA is what the plan's own multiple and a year of earnings produce, not a re-rating.

On "cheap kept losing all year," the neutral is right that the multiple has gone from about 26x FY26 earnings at 428 to 20x now, and at 665 it was about 40x. The multiple was cut in half while EPS grew 20%. That's the market pricing AI disruption, and I'm betting it's overdone. The conservative is right that strong prints haven't answered the question, but they don't need to. They need to be good enough that the multiple stops falling. Stabilization is the trade, not vindication.

I agree weekly and monthly outrank daily. The plan respects that through sizing: a quarter of target before the print, nothing above standard weight until the weekly flips. What I reject is using the hierarchy as a veto. The weekly flip needs 390.56, which is 17% higher, above the 200 SMA, and about 23.7x trailing earnings. A completed TD-9, a flattening MACD and two failures at 340-344 all say a pullback is likely. So does the plan, which is why it buys 319 and not 334. That nobody knows whether 319 holds is the reason for requiring a daily hold, not a reason to stay out.

You're right that I skipped AI substitution and free-file. AI substitution is why the multiple halved, and I won't call the Gemini small-business tools harmless. But the financials show no damage yet: revenue up 13.9%, a multi-year-high margin, off-season operating income up 97%, 44% and 40%. The one place it could show is the Q3 slowdown to 10.4%, and nobody here knows the cause. Free-file is a Q3 FY27 risk, which argues for pacing and no size above standard before tax season. It doesn't argue against a starter at about 19x trailing GAAP earnings.

Yes, earnings in late November and the December 9 FOMC are two events with gap history. But the 78% hike odds come from about $1M of unverified volume, and the stock rallied into them. With a quarter of target and a stop, I'm not betting the book on either date. The gate is an afternoon in the 10-K and 10-Q, plus the FY27 guidance nobody has pulled. If the guide supports $19, it's green. If it implies under $18, the plan says stop and call it Hold.

If a reader sees "Hold," they do nothing and miss the most likely path, an ordinary pullback of about 1.4 ATRs that holds. The neutral's "Hold with a pre-committed path to Overweight" is a conditional buy: a quarter on the hold, a quarter after a good print, the rest on evidence. I'd rather call it what it is. I back the Buy, tightened as above: 25% pre-print, B dropped, C at low-teens growth with supportive guidance, and D tied to the weekly flip or tax-season evidence. If I'm wrong, it costs 1.5% of a standard position, or 5% in the worst case. Waiting costs a stock 17% higher at a richer multiple. Aggressive Analyst: I'll give up what you've earned, then defend what's left, because I think it's smaller than the label fight makes it look.

First, the concessions. The neutral is right that I was using two trades to justify one position. The starter is a tactical trade with a tactical stop, and the business thesis gets expressed through C and D on evidence, not price. If A stops out, I'm out of a trade, not wrong about Intuit. I'll also drop two arguments. The 2.5:1 payoff was generous, since from 318 to the $341 base case against a 19.6-point stop is closer to 1.2:1. And "it rallied into the hike odds" proves little, because it rallied from an RSI of 27 on a deal and sector beta. I'll take the neutral's Tranche C fix too: low-teens revenue growth, margins holding, a guide supporting about $18.50 of GAAP EPS, and the add on a hold. A guide that supports $19 would probably gap the stock through 344, and we don't chase there. And yes, I compared a basic count to a diluted one. Two to three percent shrink is the right range.

On the gate, the conservative says an unrun gate can't rank above Hold. The plan says a failed gate means Hold, and nothing has failed. What's true is that no order should be live until it's run. I'd add one item to it: pull the 10-year yield, since FRED gave us nothing and a 4.9% earnings yield means little without it. The FY27 guide goes first. It already exists and it settles $18 versus $19. The retail claim of 2-3% FY27 TurboTax growth is unverified, but if the guide confirms that for the biggest profit pool, I fold the Buy myself. That's the one fact that would change my mind.

On the EPS fight, I'd rather use the operating-income split than argue share counts. Off-season operating income went from about $1.2B to $1.86B this year, up 55%. Tax season grew 8%. Suppose tax season grows 8% again. If the off-season quarters grow 25% after growing 55%, total operating income is up about 13%, and with 2-3% fewer shares that's EPS near $19. At 15% off-season growth it's about $18.60. If the off-season goes flat it's about $17.80. That's rough and ignores the below-the-line Q4 anomaly, which is what the gate is for. But the $18-19 range holds up, and the top half doesn't need a heroic assumption. On outcomes, the bear case is the multiple compressing to 16x on $18, which is about $288, roughly 9% below a 318 entry. The bull case is the multiple holding at today's trailing 20x on $19, which is about $380, roughly 20% above. That's about 2:1 on plausible outcomes, and it doesn't depend on the stop.

On the print and gaps, I'm not claiming the print is more likely to gap up. The neutral caught something I should have: February 3 and January 14 can't be earnings days, because the fiscal Q2 report comes after the January 31 quarter-end. So at least two of the four gap days were sector or AI-narrative days, and a halved stock produces down-skewed big-volume days almost by construction. Gap risk is on the tape every day, and staying flat through the print removes only part of it. A quarter-size starter costs about 1.5% of a standard position if the stop works and about 5% if May 21 repeats. That's what a position costs when you can't pick the day. Q1 faces an 18% revenue comp, so a low-teens number may not trigger C. Then we stay at a quarter, which is a cheap outcome.

The conservative is right that 319 is a soft level, an average of a fall and a rise. But I don't read the stop sitting just under the tested 298-301 floor as a flaw. That's where a stop belongs, since a break of the tested floor means the trade is wrong. The daily-hold requirement is there because 319 is soft. I'd also separate the two cancellations. A close under 298.38 cancels the starter and all pre-print buying. I'd re-underwrite after the print instead of treating the business as dead for good.

On the label, the substance is agreed: a standing order for 25% at 316-320 on a daily hold, after the gate, with no market order at 334.52. The headline-reader worry is real, but that's a wording problem. Lead the rationale with "do not buy at 334.52" and it's solved. A Hold with a live buy order is a Buy with a trigger, and calling it Hold understates a plan that is accumulating on the most likely path, an ordinary pullback that holds. On the neutral's market-weight point, the end state is up to 1.25x, but only on evidence, and starting below standard is how you earn that. I back the Buy, tightened as above, and the cost of being wrong is small and sized in advance. Aggressive Analyst: We're close enough that I'll say what I accept, then where I still think you're leaving something on the table.

The neutral's best new point is that none of the 25% bounce came from earnings. Trailing EPS was about $16.44 on September 29 and is $16.46 now, so the stock went from roughly 16x to 20x on a deal and sector beta. That supports my entry discipline, because the plan never paid 20x. A 318 entry is about 19.3x trailing and about 17x on $18.50. But I can't call the stock priced as broken at 334 anymore, and I'm dropping that framing. I also accept the $270 bear case. My 2:1 needed the top of the EPS range and an unchanged 20x. The honest picture is a fairly priced stock with wide tails.

I'll take the graded gate. The conservative caught that I said I'd fold on a 2-3% TurboTax guide, yet my own math gives $18.20 to $18.50 there, which an $18 cliff waves through. So $18.50 or better gets the full quarter, $18 to $18.50 gets half, and under $18 gets nothing. If the guide shows the core consumer franchise at 2-3%, C and D are off and I stop calling this a Buy. I also take the timing rule. Confirm the earnings date, fill at least a week before it or let the order lapse, make one attempt before the print, and re-underwrite afterward. If the report is late November, that leaves roughly three to four weeks for a 1.4 ATR pullback, which is plenty. And a close under 298.38 should kill the starter and all pre-print buying without killing the business case.

Here is where I still disagree. First, the starter was never the trade. Its expected return alone is a few percent, and I won't sell it as a mispricing. What it buys is ownership of the first real evidence. Both post-report drops came on prints where growth had slowed. The first print with low-teens growth, holding margins and a guide near $18.50 is the first test of the other side. The neutral is right that a halved stock gives a down-skewed tape, so nobody can claim the next gap is up. But nobody can claim it's down either, and a quarter-size position is the price of not having to guess. Waiting means that if the evidence is good, we're either chasing through 340-344, which the plan forbids, or buying much higher.

Second, the stop. The conservative and neutral both say a stop 1.6 ATRs away gets tested on noise. But the plan's stop is close-based, and last week's 298.83 low was an intraday print that closed at 310.44. In the best test we have, noise didn't touch it. A stop-out costs about 1.5% of a standard position, and a repeat of the worst gap costs about 5%. I'd accept both costs.

Third, on the conservative's point that the print is high-variance and low-information because Q1 is about 9% of operating income: the quarter itself is small, but the call is where management refreshes the outlook, and that drives the reaction. That's my understanding of how Intuit reports, not something in our tools, so check it in the gate. If the FY27 guide is already in hand and passes, the print holds fewer surprises, which you said makes it tolerable.

On macro, I agree the 10-year goes in the gate. If the spread over the 4.9% earnings yield is thin, that's an input to size, not a veto. A Treasury doesn't grow 14% a year, and the 78% hike odds sit on about $1M of unverified volume.

On the label, the conservative's headline worry is fair given that we have no portfolio context. My answer is to put the conditions in the line itself: "Buy, staged. Do not buy at 334.52. Place a 25% starter at 316-320 on a daily hold, only after the gate clears, never at market." If the gate fails, it's Hold, and the plan says so. I'd keep Buy because Hold reads as "do nothing," and pre-commitment is what stops people from either chasing at 340 or freezing at 319 when the headlines are ugly. But if the order text is identical, the practical gap between us is near zero, and I'd rather say that than manufacture a disagreement.

Here's the package. Run the gate this week: FY27 guide, repurchase table, stock comp, the Q4 net-income offset, the 10-year, and the earnings date. Size the starter by the graded gate. Skip B. Cancel pre-print buying on a close under 298.38. Add the second quarter after the print only on low-teens growth, holding margins, a guide near $18.50, and a hold rather than a chase. Go above standard weight only on the weekly flip or tax-season evidence. If you're at standard weight, don't add into 340-344. If you're overweight, trimming there is reasonable. And recheck every level after the close, since today's bar is probably partial. Aggressive Analyst: I think we're about as close as a debate gets. Most of what's left is wording and a few mechanics, so I'll give up what you've earned and then fight for the little that remains.

The August point lands. I said both post-report drops came on prints where growth had slowed, and that's only true of May. The derived fourth quarter grew about 13.7% with operating income up about 40%, and the stock still went from 368 to 267. So a clean low-teens print is necessary for my thesis, not sufficient. Whatever sank the stock in August was probably the FY27 guide or the AI narrative, which nobody here has read. I'll also stop saying the starter buys evidence. You can read the print as a non-holder. What the starter buys is participation in the most likely path, an ordinary pullback that holds, and that's worth a quarter-size position and no more.

The August setup also supports the plan's discipline. The stock ran about 46% off the June low into that print and sold off. It's now up 25% in sixteen sessions into the next one. That's the best reason never to pay 334 and to expect a pullback into the 316-320 zone. It's also a reason the fill should come at least a week before the print or lapse. That's an entry-quality rule, not risk control, and the conservative is right to say so.

I'm retiring the buyback from my argument. The neutral's cash reconciliation is a good catch. Operating, investing and financing flows sum to roughly a quarter-billion outflow while cash rose $1.8B. That's probably restricted cash and customer funds, but it means the $7.7B financing line may not be all repurchases. I shouldn't have turned it into a share-count claim, and the repurchase table in the 10-K is the number to read.

On the stop, I agree we shouldn't hard-wire 298.38. It's today's daily SuperTrend reading, and it ratchets up if price makes a new high before the pullback comes. Fix the cancel level in dollars when the order is placed and review it deliberately. A floating indicator that moves under an unfilled order is a way to get stopped out on noise.

I also accept the conservative's anchoring worry, and the 17.5x rule answers it. Tranche C only fires at no more than about 17.5x guided GAAP EPS. On a guide near $18.50 that's roughly $324, so a pop through it means we miss the add. I'd write the checklist before the print, not after. C also only takes us from a quarter to half of target, which is still below a standard position. It isn't a conviction add. Conviction waits for the weekly flip or tax season, and that's where the real money gets made or lost.

I do disagree with part of the conservative's three-case table. The FY27 guide already exists, since I believe it comes with the fiscal Q4 report. That's my understanding of Intuit's cadence, so verify it. If the gate is run honestly, a guide that implies under $18 means the order never goes live. The trimmed case is then a mid-year cut to a guide we've already read, and that's the roughly 5% scenario I've been pricing. The raised case means we miss upside beyond a quarter-size position, and I accept that cost. Those are the two prices of this plan. The neutral had it right: carrying the print is no edge, not negative edge. Whatever edge exists is in the price. A 318 fill is about 19.3x trailing GAAP earnings, against 20.3x today and 16.2x three weeks ago.

The correlation point is the best new idea of the round, and I'd extend it. If the caller already holds ADBE, DOCU, MDB or MNDY at full weight, I wouldn't add INTU on top. I'd fund it from the software name they trust least, or skip it. That keeps the bet on the AI-disruption multiple from getting bigger while still owning the business with the 27% operating margin and the cleanest evidence of operating leverage.

On the label, I'll be direct. If the order text is identical, the gap between us is a word. But Hold has a failure mode too. Someone reading "Hold, upgrade later" treats the gate as optional, never runs it, and the standing order never gets placed. Then either they freeze at 319 when the headlines are ugly, or they chase at 345 after the guide is out. A Buy with the conditions written into the line puts the pre-commitment in front of them. If the desk prefers the neutral's wording, I can live with it, provided the gate has a deadline this week and the upgrade isn't left to memory.

So the package I'd stand behind is this. Don't buy at 334.52 and don't add into 340-344. This week, run the gate: the FY27 guide, the repurchase table, stock comp, the Q4 net-income offset, the 10-year yield, the earnings date and the caller's existing software exposure. If the guide supports $18.50 or better, place a 25% starter at 316-320 on a daily hold. Between $18 and $18.50, place about half that, and it never counts toward C. Below $18, or if the guide shows the core consumer tax franchise growing 2-3%, it's a Hold and I stop calling this a Buy. Skip Tranche B, make one attempt before the print, and re-underwrite afterward. Add the second quarter only on low-teens growth, holding margins, a guide near $18.50 and a price at or under about 17.5x it. Nothing goes above standard weight until the weekly closes above 390.56 or tax season shows low-teens growth again. And recheck every level after the close, since today's bar is probably partial.

My position is Buy, staged. It costs about 1.5% of a standard position if the stop works and about 5% in a repeat of the worst gap. In return it keeps us in the one scenario the plan expects, a pullback that holds.

Conservative Analyst¶

Conservative Analyst: I'll start by agreeing that most of your arithmetic is right. The 2.5:1 and 3.7:1 numbers check out. My problem is that they rest on a stop the plan itself says it doesn't trust. Tranche B is explicitly "sized for a gap risk of about 20% rather than a close-based stop." You can't use a 19.6-point stop to sell the reward/risk and then size for a 20% gap to sell the safety. A 20% gap from 318 is roughly 64 points, and against that the payoff to the 200 SMA is under 0.8 to 1, and to 390 about 1.1 to 1. That's the real trade.

The stop also conflicts with Tranche B. It buys at 298 to 305, but a daily close below 298.38 flips the daily SuperTrend down and lines it up with the weekly and monthly. So the plan adds exposure at the point where its own signal says the bounce failed.

On "priced for a worse outcome than the numbers show," that argument has been available all year and it kept losing. At 428 the stock was 38% off the high, and at 380 it was 45% off. Margins and EPS improved the whole way, and it still dropped 20% in a day and bottomed 33.6% below 380. That takes a 50% gain to recover. The market isn't pricing last year's numbers. It's pricing terminal value under AI disruption, and strong prints haven't answered that. Even your director, who bought near the lows at $309.50, was down about 18% a month later. His $542K is about 0.0006% of the market cap. Dalzell sold more than that at lower prices in June, and net insider activity since April is a wash. Scott Cook not selling at half price isn't buying.

I'll give you part of the buyback point. Liabilities rose over the year, so it's probably more buyback than debt paydown, though dividends at the current yield are around $1.5B of the $7.7B. But a buyback was running while the stock fell from 380 to 252, and it did nothing for holders on May 21. Equity also shrank 3.6%.

On the technicals, ADX at 31 isn't a regime shift. It was 34.7 on September 29, at the bottom of the down-leg. ADX has no direction, and it spikes after any violent V. Your trend filters being late is a fair point. But the technical report ranks weekly and monthly above daily, and this plan buys against both. Price has also failed twice at 340 to 344, with the TD-9 complete and the MACD histogram ticking down from its peak. That makes a pullback to 319 likely, and what matters is whether that level holds, which nobody knows today. Remember too that the last bar is probably partial.

On valuation, you said the failure case is $324 at 18x on $18 EPS. That's fair value, not a margin of safety, and a 318 entry is a 2% discount to it. The 18x is itself a judgment, and with a 78% December hike probability it's the number most likely to compress. At 16x on $18.90 you're at about $302, right on the stop. The 7% FCF yield is before stock comp, which we don't have. FCF running well above net income is typically driven by non-cash charges like that.

The gate and the add triggers worry me most. Step 0 needs the Q4 net-income offset, Q3 segment growth and FCF net of SBC, and none of those are in hand. You say the dip is a couple of sessions away, but the diligence won't be done in a couple of sessions. Then the add trigger for Tranche C is revenue growth of about 10%, which is the 10.4% quarter that triggered the crash. Last year's Q1 grew 18.3%, so a 10% print would be an eight-point deceleration. Q1 is also only about 9% of operating income, while Q3 is about two-thirds. A decent Q1 tells you almost nothing about the quarter that matters, and Credit Karma's free federal filing lands right in front of it.

You called the macro backdrop survivable, and I won't say it isn't, but I'd point to the calendar. The earnings date is probably late November and unconfirmed, and the December FOMC resolves on the ninth. That's two binary events in about two weeks. Beta of 1.0 and 8% recession odds don't capture a stock that gaps 20%. The tools don't say what caused the May 21 and August 26 gaps, but the timing lines up with quarterly reports. The risks I'd worry about are AI substitution, like the Gemini small-business tools, and free-file cannibalization, and you didn't address either.

On sentiment, five Sequence headlines are one catalyst, and the deal terms are unverified. Part of the pop was sector beta, since Adobe, DocuSign, MongoDB and monday.com all moved with it, and that can reverse just as fast. Nine authors and "meme coin move" language aren't the base you want under a position.

I accept that caution isn't free. But the plan's last tranche already waits for a weekly close above 390.56, so we both accept paying up for confirmation. The disagreement is whether to hold real exposure before any evidence on the quarter that matters, through two events with a history of big gaps.

My recommendation is to downgrade Buy to Hold for now. If you're flat, wait through the print. If you hold a standard weight, don't add. If you're overweight, trimming into 340 to 344 is reasonable. If the desk insists on starting, I'd cap pre-print exposure at 25% of target, in Tranche A only, and only after the gate is done with real numbers. I'd drop Tranche B and treat a close below 298.38 as cancelling the whole plan. And I'd raise the Tranche C and D triggers to roughly the 13 to 14% growth FY26 delivered, with guidance that supports at least $19 of EPS, and tie D to the weekly flip rather than Q1 alone. Conservative Analyst: You two have narrowed this a lot. Tranche B is gone, the 10% trigger for C is gone, and ADX and the director are footnotes. That was most of what I came to argue, so I'll spend my time on what's left, which is more than a label.

The first issue is something nobody has read. FY26 ended July 31 and the 10-K is filed. The August 26 gap very likely sits on the Q4 report, which is where management gives FY27 guidance. That number decides whether this is an $18 or a $19 name, and it already exists. The aggressive's own gate says that if the guide supports $19 it's green, and if it implies under $18 you stop. A Buy that depends on a number nobody has looked at isn't a Buy yet. By the plan's rule, a failed gate means Hold, and an unrun gate can't rank above that.

The price path matters too. The stock went from about 368 on August 24 to 267 on September 29, then back to 334. That retraces about two-thirds of the post-print drop, and the only identified drivers are Sequence and a sector bounce, not a change in the guide. If the guide was what hurt, you're being asked to buy the retrace.

On the stop, the aggressive says it defines the thesis and sizing handles the gap. But the stop is 19.6 points under 318, about 1.6 ATRs, and the stock traded to 298.83 a week ago. The thesis is a twelve-month roll-forward to 370-390, while the stop is a noise-level daily stop. If the stop is real, ordinary volatility can take you out of a thesis that's right. If you widen it, the 2.5-to-1 disappears.

That roll-forward also needs FY28 earnings of about $20.50 to $21.70 at 18x. From the $341 base case, $380 a year out is about 11%, roughly a cost of equity. That isn't what a 2.5-to-1 payoff was advertising.

"Gaps run both ways" is true in principle, but not in this tape. As far as the data shows, every large-volume event is a drop: January 14, February 3, May 21 and the August move. The 25% rally was sixteen sessions of grinding on a deal and sector beta, not an upside earnings gap. The stop is also close-based, so in a gap it doesn't bind. The 1.5% cost is the best case, and 5% assumes the next gap is no worse than the last. The starter then sits through a probable late-November print and the December 9 FOMC. Holding through the print only has positive expected value if the print is more likely to gap up than down, and nothing here says that.

On the buyback, the aggressive conceded up front that the split isn't in the data, then used $3.7B of repurchases to get a 3% smaller share count. The 267M comes from market cap over price, which is probably a basic count, and he's comparing it to a 277M diluted figure. The equity roll gives a cross-check. Equity fell $1.64B in Q4 while net income added $0.36B, so buybacks plus dividends outran stock comp by about $2B. Unless stock comp was unusually large, that suggests a Q4 repurchase nearer $2B to $2.5B, with the rest of the outflow being something else. That's my estimate, not reported data. Cut the shrink to 1-2% and $18.90 needs about 13% net income growth, not 11%. The tax-season profit pool, two-thirds of the total, grew operating income only 8% last year.

So the neutral is right that $18 to $19 is the honest range, which is $324 to $342 at 18x. The stock is at 334, and a 318 entry sits 2% under the failure-case fair value. That is not a margin of safety.

I'll grant the 4.9% earnings yield is a better number than the FCF yield. But FRED returned nothing, so we have no Treasury yield to say whether 4.9% is cheap, and the only rate evidence we do have points to hikes. "Stabilization is the trade" is an argument about the multiple, not about value. The multiple halved while prints were beating, and nothing in the numbers says the next one stops it.

The 319 level is also softer than it sounds. The 10 EMA and 50 SMA are averages of a 27% fall and a 25% rise, and they converge there arithmetically. The level price has actually tested is 298-301, which the plan abandons, and which sits at the stop. So the plan buys an untested average and stops out just under the only tested floor.

On the label, the aggressive says Hold means doing nothing and missing the pullback. But the plan's action today is nothing, and a conditional order survives under either name. The label only changes what happens to someone who reads just the headline. We have no portfolio context, so a flat reader sees Buy and buys at 334.52, and a reader at standard weight adds. I'd rather the headline match the action. As for waiting costing a stock 17% higher, that's the weekly flip, which Tranche D pays anyway.

My recommendation is Hold today, with the starter pre-authorized if the desk wants it. That means 25% of target, Tranche A only, at 316-320 on a daily hold. It goes in only after the gate is run with the FY27 guide and stock comp in hand, and a close under 298.38 cancels the whole plan. Raise C to low-teens growth with guidance supporting at least $19, tie D to the weekly flip, and recheck every level after the close, since today's bar is partial. Reading one document costs nothing, while buying before reading it can cost real money. Conservative Analyst: We're down to a small gap, so I'll concede what I should before arguing the rest.

The neutral is right about January 14 and February 3. Fiscal Q2 closes January 31, so neither can be an earnings day, and I was wrong to read all four gap days as report days. The two that plausibly line up with the report cycle are May 21 and August 26, and both were drops. Two of two is a thin sample, but it's the only one we have on this exact event. I'll also take the neutral's correction on Tranche C. A guide supporting $19 probably means the stock is already through 344, so I'll drop that trigger. I accept the buyback correction too: $2 to $2.5B retired at those prices is nearer 3% than 1-2%, and the repurchase table will settle it.

Now the aggressive's operating-income math. It's the cleanest piece in the debate, and I checked it. The off-season quarters did go from about $1.2B to $1.86B, and tax season grew 8%. But look at what carries the answer. The off-season base is about $1.9B against $4.0B in tax season. Even if the off-season grows another 25%, a flat tax season gives you about $18.20. If tax-season operating income grows 2 to 3%, which is where that retail post puts TurboTax, the same framework gives roughly $18 to $18.50. You said you'd fold on that fact. But at 18x that's $324 to $333, and the plan's gate only trips below $18. So the gate as written passes on the very outcome that makes you fold. I'd set the gate at $18.50 for both Tranche A and Tranche C. At $18 a 318 entry is a 2% discount to fair value, and at $18.50 it's about 5%.

On the bear case, 16x on $18 is $288, but that isn't a bear case. By my derived quarters, trailing EPS in late June was about $16.44, so the June low of 252.77 was about 15.4x. The market has already paid that multiple, three months ago, with the same earnings. A 15x multiple on $18 is about $270, down 15% from 318. Against your $380, that's 1.3:1 at best, and closer to 1:1 if June gets retested. Your bull case also needs the top of the EPS range and an unchanged 20x, which is above the 18x the plan calls fair. At 18x on $19 you're back at $342, the same resistance zone.

On gaps and the print, I'll concede that holding a quarter-size position costs about 1.5% to 5% of a standard position. My objection is that the print is high-variance and low-information about what matters. The reaction will come from the guide and the AI narrative, not from Q1's roughly 9% of operating income. So you take gap variance without learning anything about tax season. That's more tolerable if the FY27 guide is already in hand and passes, because then the print is less likely to hold a surprise. So I'll live with a starter riding the print, but only after the gate is run with the guide read, and only if the earnings date is confirmed.

On the label, you now agree no order should be live until the gate is run, which means the action today is nothing. Calling that Buy is the mismatch. Consider the paths. If the stock pulls back and holds, the order fills at 316 to 320 whatever the headline says, so Hold costs you nothing. If it doesn't pull back, the label only matters to a reader who acts on it, and that reader buys at 334.52 or adds at standard weight. We have no portfolio context, and the final line is what gets read. A rationale that opens with "do not buy at 334.52" doesn't survive a headline parse. When the gate passes and the order goes live, upgrade the rating then, on evidence.

For the 10-year yield, I agree it belongs in the gate. A 4.9% earnings yield means nothing without it. Directionally, the 97% no-cuts market on $9M of volume is the deeper one, and it says the cushion software multiples enjoyed in easier years isn't coming back.

So my position is Hold today. Run the gate this week, with the FY27 guide, the repurchase table, stock comp, the Q4 net-income offset and the 10-year yield. If it clears $18.50, place the 25% starter at 316 to 320 on a daily hold. Cancel on a close under 298.38, skip B, and add the second quarter only on low-teens growth and a hold, priced at a real discount to 18x guided EPS. Anything past that waits for the weekly flip or tax season evidence. Conservative Analyst: We've converged on the same order: 25% of target at 316 to 320 on a daily hold, gate first, nothing at 334.52, no Tranche B, and everything cancelled on a close under 298.38. I'll take the graded gate. The neutral is right that a hard $18.50 switch is false precision. What's left is the label, what holding through the print buys us, and what the later tranches are really paying for.

Aggressive, you say the starter buys ownership of the first real evidence, and that a print with low-teens growth, holding margins and a guide near $18.50 is the test of the other side. We already have a print that looked roughly like that. Derived fiscal Q4 revenue was up about 13.7%, up from 10.4% in Q3, and operating income was up about 40%. The stock then fell from about 368 to 267 over the next five weeks. The August 26 gap is inferred and the tools don't say what drove it, so I hold that loosely. Still, if low-teens growth and expanding margins didn't stop the selling last time, they can't be the test that shows the multiple has stabilized. What probably moved the stock was the FY27 guide and the AI narrative, which is exactly what nobody has read. That's why the gate comes first, and why Q1's own numbers tell us little. And 17x on $18.50 isn't a floor either, since the market paid 15.4x in June and 16.2x three weeks ago.

You also keep saying that if the evidence is good, we're chasing or buying higher. The plan forbids chasing through 340 to 344, so it has already agreed to miss that path. The only path where the label changes anyone's P&L is the one where someone buys at market, and we all agree that's wrong.

You said the call is where management refreshes the outlook and drives the reaction. I agree, and it cuts against you. Take a quarter-size holder through the three cases. If the guide is raised, the stock probably gaps through 344 and you're up, but the plan won't add. If it's reaffirmed, we learn little, and that's the case where Tranche C most likely fires, on the print that taught us the least. If it's trimmed, the gate that justified the starter has failed and you're holding through the gap. Both report-cycle gaps in the data went down. I'm not saying the next one will, only that this isn't a position that gets paid for the information it takes on.

On the stop, one intraday low of 298.83 that closed at 310.44 is a single observation, not proof of a floor. A close-based stop doesn't bind in a gap anyway, which your own 5% figure assumes. I never said the dollar cost of the starter was large, and it isn't. My concern is what a starter becomes. Once you own it, the next tranche gets read by someone who's already in, and "evidence required" slides into "evidence found." That's why I'd want Tranche C tied to a real discount to guided earnings, not just a checklist of triggers.

Neutral, I'm with you on Hold, with two pushes. First, the timing rule. A fill a week before the print is still a position held through the print, so the gap risk is identical to a fill three days before. The rule improves entry quality, which is worth having, but it isn't risk control, and we shouldn't present it as the answer to the print question. The earnings date also isn't confirmed. Without a date the rule can't be applied, so no live order until we have one. Second, the half-size band at $18 to $18.50 is, by your own description, a chart trade against the weekly and monthly trends with a 2% cushion. At about 12% of target it costs under 1% of a standard position at the stop, so I won't fight it. I would say it should never count toward Tranche C. If the guide lands there, we hold that sliver and wait.

One point nobody has raised is correlation. The bounce was partly sector beta alongside ADBE, DOCU, MDB and MNDY, and we don't know what else the caller holds. A quarter-size INTU tranche looks small, but for anyone with software exposure it trades on the same AI headline as the rest of the book. The cap should be set against total software exposure, not INTU alone.

On the label, aggressive, you said that if the order text is identical, the practical gap between us is near zero. Then pick the label that fails safe. A reader who sees Hold on a day the plan says do nothing does the right thing. A reader who skims Buy may lift the offer at 334.52. The pre-commitment you want lives in the order, not in the word at the top. I'd use the neutral's wording: Hold today, and upgrade to a Buy starter once the gate clears, at 316 to 320 on a daily hold, never at market. That upgrade is a one-line change when the evidence arrives.

So my position is Hold. This week, read the FY27 guide, the repurchase table, stock comp, the Q4 net-income offset, the ten-year yield and the earnings date, and recheck every level after the close, since today's bar is probably partial. If the gate clears, place the graded starter, with no re-entry before the print after a stop-out. Skip B, and cancel pre-print buying on a close under 298.38. Add nothing after the print unless growth is low-teens, the guide is near $18.50, and the price is at a real discount to it. Nothing goes above standard weight until the weekly flips or tax season shows growth again. If you're at standard weight, don't add. If you're overweight, trimming into 340 to 344 is reasonable. Conservative Analyst: We've converged on the order, so I'll say what I'm taking from you and then push on the small gap that's left.

Accepted: the cancel level gets fixed in dollars when the order is placed, not left to a floating indicator. The 17.5x condition on the second tranche is a real improvement, and the graded gate is better than a cliff. The correlation point stands, and the starter should be funded from, or skipped against, whatever software the caller already owns. I'll also withdraw my own $2 to $2.5B Q4 repurchase estimate. It came from the equity roll, and the neutral's reconciliation shows why that was shaky. Operating, investing and financing flows sum to about a quarter-billion outflow while cash rose about $1.8B, a gap of roughly $2.1B that none of us can explain from here. The repurchase table in the 10-K is the only number worth arguing about.

Now the label. The aggressive says Hold has a failure mode: someone treats the gate as optional, never places the order, and then freezes or chases. That's real, but compare the costs. If Hold fails, you miss a quarter-size starter. A 10% move on that is worth about 2.5% of a standard position. If Buy fails, a reader who skims the headline lifts the offer at 334.52 for the trader's stated 1.0x target, and a repeat of May 21 costs about 20% of a standard position. The plan's 5% only exists if the plan is followed. So I'll take your fix and make it concrete. The gate gets a deadline at the end of this week, and the upgrade is a written one-line change with the price, the hold test and "never at market" in it. Then the word at the top does the safe thing for the reader who only reads the word.

On the edge, the aggressive is right that it sits in the price, at 19.3x trailing at a 318 fill, 20.3x today and 16.2x three weeks ago. But look at what that edge is. It's about 5% of price improvement against today, on a position we all agree has no edge in carrying the print. The same multiple went from 16x to 20x without a dollar of new earnings, on a deal and sector beta, and it can go back as fast. That's a decent tactical entry. It's not a mispricing, and a Buy rating promises one.

The 17.5x rule fixes anchoring, but it creates a different problem. Tranche C only fires when the stock is at or below roughly $324 after a print with good numbers. That is the August pattern: 13.7% revenue growth, operating income up about 40%, and the stock fell about 27% in five weeks. If the checklist is met while the stock is falling, you'd be adding into the same decline the first time. So "on a hold" needs a definition in dollars and days. I'd require several sessions above the post-print low and above the cancel level, not one green close. If the market sells a print that passes our checklist, the market is pricing something the checklist doesn't capture, and we shouldn't average into it.

Same for the starter's daily hold, which is still unspecified. I'd write it as two consecutive daily closes at or above 316 after a touch of the zone, filled the next session at no more than 320. The 319 level is an average of a fall and a rise, so the hold is the only evidence we'll have. Write it down now, because discretion is where plans drift.

On the gate, I'd stay clear about what it can do. The FY27 guide has been public since August, so the market has already traded it, down to 267 and back to 334. Reading it gives us no edge. It only tells us whether the $18 to $19 range holds. The gate can veto a purchase but it can't create the case for one, and the case for owning is a multiple that stops falling, which no document verifies. That's another reason to size this as a tactical trade.

The first item in the gate should be the segment guide for the consumer tax franchise. The retail claim of 2 to 3% TurboTax growth is unverified and ambiguously worded, but all three of us agree it's the one fact that would change the call, and tax season is two-thirds of profit. The aggressive says he'd fold on it. Good. It also means the half-size band never counts toward the second tranche, which you've already conceded.

My position is Hold today, with the upgrade written into the same line. Don't buy at 334.52 and don't add into 340 to 344. This week, run the gate in this order: the consumer segment guide, the repurchase table, stock comp, the Q4 net-income offset, the ten-year yield, the earnings date and the caller's software exposure. If it clears, place a starter sized by the graded gate, 25% of target at $18.50 or better, about half that between $18 and $18.50, and nothing below $18. It fills on the two-close hold, at least a week before the print or it lapses, with one attempt. Skip the 298 to 305 tranche. A close under the dollar cancel level ends pre-print buying, and the business case gets re-underwritten after the print. After the print, the second quarter needs low-teens growth, holding margins, a guide near $18.50, a price at or under about 17.5x that guide and a multi-session hold. Nothing goes above standard weight until the weekly closes above 390.56 or tax season shows low-teens growth again. If you're flat, wait for the pullback. If you're at standard weight, don't add. If you're overweight, trimming into 340 to 344 is reasonable. And recheck every level after the close, since today's bar is probably partial.

Neutral Analyst¶

Neutral Analyst: I think you two are arguing harder than the gap between you justifies. Nobody is buying at 334.52 today. The trader's plan allows at most half the target before the print, and the conservative would allow a quarter. So the Buy-versus-Hold fight is really about one 25% tranche at 298 to 305, a couple of add triggers, and what to call the thing.

To the aggressive side first. The 2.5 to 1 payoff uses the 200 SMA at 367.51 as the target. But the plan's own valuation, 18x on about $18.90 of GAAP EPS, gives roughly $341, which is almost exactly the 340-344 zone that has capped price twice. So base-case value and first resistance are the same place. From 318, a move to 341 is 23 points against a 19.6-point stop, closer to 1.2 to 1. You only get to 2.5 if you assume the 20% growth case or a re-rating.

I'd also challenge that 20% case. Using the derived quarters, the three off-season quarters earned $3.65 in FY25 and $5.37 in FY26, up 47%. The tax-season quarter went from $10.02 to $11.09, up about 11%. Off-season growth has been fading, too: Q1 more than doubled, Q2 rose about 48%, and the derived Q4 was flat at $1.30 versus $1.28, with net income down 5% despite operating income up 40%. If tax season grows 11% again, reaching $18.90 needs the off-season quarters up about 23% off a base that just rose 47%. Reaching $19.80 needs about 40%. Hitting $18 needs only about 6 or 7%. So FY27 GAAP EPS of $18 to $19 is the honest range, which at 18x is $324 to $342. At $334 the stock is already in the middle of that, so it isn't priced as if broken. It's priced as a mid-teens grower at a normal multiple.

The cushion arguments are also weaker than they sound. Operating cash flow ran about $4.3B above net income, and depreciation explains maybe a billion of that. The rest is stock comp and working-capital timing, and we can't split them, so the 7% FCF yield is probably lower after SBC. The buyback is mostly share-count arithmetic, roughly 2% fewer shares, which is already in the EPS growth. It's not a signal of a bottom.

To the conservative side. You're right about ADX, which read 34.7 at the bottom of the down-leg, and right that Tranche B is incoherent with the stop. Buying at 298 to 305 when a close below 298.38 cancels the signal means adding exactly when the plan says the thesis is failing. Drop it before the print. Though note that's worth about 5% of a standard position in a 20% gap, so it's a logic fix more than a risk fix.

But some of your points overreach. "The cheap argument kept losing all year" ignores that at 428 the stock was about 26x what FY26 ended up earning, and now it's about 20x. The multiple has compressed by roughly a quarter while earnings grew, so it's a different bet. The 0.8 to 1 gap-adjusted payoff treats a tail event as the typical outcome. The stop defines the thesis, and sizing handles the gap. Those are separate jobs. Also, Tranche A requires a daily hold of the 316-320 zone, so it isn't a falling-knife buy.

On Step 0, the Q4 offset, segment growth and SBC are all in the 10-K and 10-Q. That's an afternoon of reading. There's also one thing nobody has pulled: FY27 guidance. The August 26 gap looks like a down move, since the stock was 368 on the 24^th and an officer sold near 346 on the 27^th, and it probably sits right on the Q4 report. Management's EPS guide and the consumer tax outlook would settle the $18 versus $19 argument better than anything here. One retail post claims 2 to 3% TurboTax growth, which is unverified but hits the biggest profit pool.

You're also right that Q1 is only about 9% of operating income and a weak test. But that cuts both ways, because Q1 faces an 18% revenue comp and a 97% operating income comp, so a so-so number could be noise. Free-file is a Q3 FY27 risk, not a Q1 one, which is a reason not to reach full size before April, not a reason to stay flat. The December hike is 78% priced in a thin, unverified market, and the stock rallied 25% into it. Rates aren't the binding constraint; the AI-disruption multiple is.

Where I land: no purchase at 334.52. Place a conditional starter of 25% of target at 316-320, only on a daily hold and only after Step 0 including FY27 guidance. A stop-out costs about 1.5% of a standard position. Skip B before the print. Add the next 25% after the print only if revenue growth is low-teens or better, margins hold, and the GAAP guide supports around $19. Hold the back half until the weekly flips above 390.56 or tax season shows growth back in the low teens, and no sizing above standard until then. Re-check the levels after the close, since today's bar is probably partial. I'd label it Hold today with a pre-committed path to Overweight, not a Buy. Neutral Analyst: You've converged more than the tone suggests, so I'll start with what's settled and then go after what each of you is still holding onto.

Both of you now describe the same order: 25% of target at 316 to 320, only on a daily hold, only after the diligence gate, with a close under 298.38 cancelling the plan and nothing bought at 334.52. Tranche B is gone. What's left is the label, whether that starter rides through the print, and where Tranche C triggers.

Aggressive, you're using two different trades to justify one position. The stop is about 1.6 ATRs away, and the stock traded to 298.83 a week ago. But the case for owning it is a roll-forward to 370 or 390 over a year. A noise-level stop can't protect a twelve-month thesis, and a twelve-month thesis doesn't make a 2.5-to-1 payoff measured against that stop meaningful. I'd treat the starter as a tactical trade with a tactical stop. The fundamental thesis gets expressed through C and D, which should be triggered by evidence, not price. If A gets stopped, you haven't been wrong about the business, you're just out of a trade. As the conservative noted, the roll-forward is also only about 11% a year from the $341 base case, which is a fine return but not a mispricing. And "it rallied 25% into the hike odds" proves less than you want. It rallied from an RSI of 27, on a deal and sector beta. That's an oversold bounce, not evidence the multiple is immune to rates.

You're also half right that my Hold-with-a-path is really a conditional buy. But look at the sizing. It's one times a standard position, nothing above that until the weekly turns at 390.56, and with B dropped, a quarter of target before the print. That's market-weight accumulation. Overweight, and Buy as its mapping, promises more conviction than the sizing carries.

Conservative, I'll take your core point wholesale: the gate hasn't been run, and the FY27 guide already exists. But your case for sitting out the print has a hole. You read the big-volume drops as lining up with quarterly reports. Intuit's second quarter ends January 31. February 3 can't be that report, and January 14 is mid-quarter. Unless there was an unscheduled announcement the tools don't show, at least two of your four gap days were sector or AI-narrative days. So gap risk is on the tape every day, and staying flat through the print removes less of it than you imply. Size is the control, and it's already small. The tape is also one-sided partly because the stock halved. Big-volume days in a year like that skew down by construction, so it doesn't give either of you a distribution for the next print.

You also can't argue that Q1 is nine percent of operating income and tells us almost nothing, and then treat it as the binary event to avoid. A low-information print should change how much I add afterward, not whether I can hold a quarter-size position into it.

Your Tranche C trigger has a different problem. Guidance supporting at least $19 is the top of the $18 to $19 range we all agreed on. If the guide supports $19, the stock is probably not at 320 anymore. It's through 340, and the plan's own rule says never add through resistance. So that trigger can't be met at a price the plan allows. I'd set it at low-teens revenue growth, margins holding, and a guide supporting around $18.50 GAAP, with the add made on a hold rather than a gap.

On the buyback fight, you each slipped. Aggressive, you compared a basic share count to a diluted one. Conservative, your own estimate of $2 to $2.5B of Q4 repurchases at prices between roughly 250 and 330 retires seven to nine million shares. That's around three percent, and much of it isn't in the FY26 weighted average yet. So your one to two percent doesn't fit your own math. Call it two to three percent. At that shrink, $18.90 needs net income growth of about 12%, against 18% last year, and the off-season quarters need to slow from roughly 47% per share growth to around 20%. That's a big deceleration, but from a small base. It's plausible, not assured. The whole dispute is worth less than half a turn of multiple, so I wouldn't spend more time on it. The 10-K cover page and the repurchase table settle it.

Here's a shortcut for the gate. The $26.94 forward EPS is probably non-GAAP. Pull FY26 non-GAAP EPS from the Q4 release, take last year's GAAP-to-non-GAAP ratio, and apply it to $26.94. That gives a rough GAAP forecast that doesn't depend on anyone's share-count guess, and you can check it against the management guide.

So here's where I land. I'd label it Hold today. The plan's own rule says a failed gate means Hold, the gate hasn't been run, the sizing is market-weight, and with no portfolio context a Buy headline next to a 334.52 print invites a market order the plan explicitly forbids. Then run the gate this week: the FY27 guide, the share count and repurchase table, stock comp, and the Q4 net-income offset. If it passes, place a standing order for 25% of target at 316 to 320 on a daily hold. Cancel everything on a close under 298.38, skip B, and keep pre-print exposure at that quarter.

After the print, add another 25% if revenue growth is low-teens or better, margins hold, and the guide supports roughly $18.50 of GAAP EPS. The add should come on a hold, not through 340 to 344. Anything beyond one times standard waits for the weekly flip or tax season showing low-teens growth again. If you're already at standard weight, don't add into 340 to 344. If you're overweight, trimming there is reasonable. And recheck every level after the close, since today's bar is probably partial.

That gets most of the aggressive case's upside, because the starter is live on the most likely path, an ordinary pullback that holds. It also gets most of the conservative case's protection, because nothing gets bought on a document no one has read. Neutral Analyst: We're down to one order and a few details, so I'll go through the details and push on both of you where you're still stretching.

Aggressive, start with the payoff. The conservative's catch on the bear case holds up. The June low of 252.77 was about 15.4x the trailing EPS of the time, so 15x on $18 is about $270. That's roughly where the September low sits, so the bear case is a retest of a level price visited three weeks ago, not a tail. Your bull case needs the top of the EPS range and a 20x multiple, which is above the 18x the plan calls fair. Laid out honestly, the bear case is about $270, 15% under a 318 entry. The base case is $324 to $342, roughly 2 to 7% above. The bull case is $360 to $380, 13 to 20% above. That's a fairly priced stock with wide tails both ways. It's a reasonable thing to own a quarter of, but it isn't a mispricing, and a Buy rating implies one.

Nobody has pointed out that none of the 25% bounce came from earnings. Trailing EPS was about $16.44 on September 29 and is $16.46 now. At 266.79 the stock was 16.2x, and at 334.52 it's 20.3x. Every dollar of the move was multiple. So "stabilization is the trade" has already been partly delivered, and the cheap part of your thesis was cheaper three weeks ago. That's a strong argument for 316-320 over 334. Conservative, it also cuts your way, because a multiple that re-rated 25% on a deal and sector beta can de-rate on the next AI headline.

On the gate, the conservative caught something real. The aggressive said he'd fold if the guide confirms 2-3% TurboTax growth. His own operating-income math gives about $18 to $18.50 in that case, and the gate as written only trips below $18. So it wouldn't catch the one fact he says would change his mind. I'd fix it with a graded gate instead of a cliff. If the guide and the cross-checks support $18.50 or better, the starter is the full 25%. Between $18 and $18.50, it's half a starter, around 12%. Below $18, nothing, and it's a Hold. At $18.50 and 18x, fair value is about $333 and a 318 entry has a 5% cushion. At $18 the cushion is 2%, and the starter is a pure chart trade against the weekly and monthly trends, so it should be sized as one. A hard $18.50 on/off switch is false precision, because $18.40 versus $18.60 is inside anyone's error bar, including management's.

On the print, I still think a filled quarter-size position can ride it. But the conservative is right that you take gap variance and learn little about tax season, and the aggressive is right that you can't pick the day. One timing rule handles both. Once the earnings date is confirmed, the starter only gets initiated if it can fill at least a week before the print. A pullback buy is a bet that the pullback holds, and that needs time to show itself. A fill three days before the report is a bet on the report. If it hasn't filled a week out, let it lapse and re-underwrite afterward. The same goes for a stop-out: one attempt before the print, no re-entry until after it. That matters because a stop 1.6 ATRs away, on a stock that traded 298.83 last week, will probably get tested on noise. Neither 319 nor 298-301 is a proven level. One is an average and the other is a week-old higher low in a rally. That's another reason to keep the starter small and tactical.

On cancellation, a close under 298.38 should kill the starter and all pre-print buying. It shouldn't kill the business case or restore it automatically. Re-underwrite after the print at whatever price the stock has. That splits your positions fairly.

On macro, the 78% hike odds sit on about $1M of unverified volume, and I wouldn't let them veto anything. But I agree the 10-year belongs in the gate. Compute the 4.9% earnings yield against the risk-free rate. If the spread is thin, the stock has to earn its return through growth, and growth in the tax-season quarter is exactly what's in doubt.

On the label, I'm staying at Hold today. Aggressive, a Hold with a live order is a Buy with a trigger, and I won't pretend otherwise. But the order isn't live, and by your own concession shouldn't be until the gate runs. Conservative, I don't need the label to do more than that. Write the upgrade condition into the line itself: Hold today, upgrade to Buy (starter) when the gate clears, only at 316-320 on a daily hold, never at market. That survives a headline parse and costs the aggressive nothing if the pullback comes.

My recommendation is this. Don't buy at 334.52. This week, run the gate: the FY27 guide, the repurchase table, stock comp, the Q4 net-income offset, the 10-year yield and the earnings date. Then place a starter sized by the graded gate, with a daily-hold trigger. Skip Tranche B before the print, and cancel everything on a close under 298.38. Add the second quarter after the print only on low-teens revenue growth, holding margins, a guide near $18.50, and a hold rather than a chase through 340-344. Nothing above standard weight until the weekly flips or tax season shows low-teens growth again. If you're flat, don't chase. If you're at standard weight, don't add into 340-344. If you're overweight, trimming there is reasonable. Recheck every level after the close, since today's bar is probably partial. Neutral Analyst: We're down to a headline and a few details, so let me take what's left and then give you the package as I'd write it.

Aggressive, one of your remaining arguments doesn't hold up. You said both post-report drops came on prints where growth had slowed. That's true of May, when the April quarter grew 10.4%. It's much less clear for August. The derived fourth quarter grew about 13.7%, up from 10.4%, with operating income up about 40%, and the stock still fell from 368 to 267 over the next five weeks. It had also run about 46% off the June low into that print. Now it's up 25% in sixteen sessions, with no earnings behind it, heading into the next one. The August cause is inferred, so I hold that loosely. Still, a clean low-teens print looks necessary for your thesis and not obviously sufficient. I also don't think the starter buys you evidence. You can read the print as a non-holder, and Tranche C is conditional on it either way. What the starter buys is participation in the most likely path, a pullback that holds. That's worth a quarter-size position and no more, so describe it that way. On the stop, I'll give you the 298.83 intraday low that closed at 310.44. It's one observation, but it's the one we have. Just don't hard-wire 298.38. That's today's daily SuperTrend reading, and it can move before anything fills.

Conservative, you're right that a starter can become an anchor, and that "evidence required" can quietly turn into "evidence found." The fix is to write price into the rule, not to stay out. So I'd add one condition to Tranche C: pay no more than about 17.5x guided GAAP EPS. On a guide near $18.50 that's roughly $324, a real discount to the $333 that 18x gives, without demanding a retest of June. If the stock gaps through that on good news, we don't add and we accept missing it. Your three-case table for the print is a fair description of the position, but it applies to anyone who already owns the stock. What it shows is no edge in carrying the print, not negative edge. At about 1.5% of a standard position at the stop and 5% in the worst gap, I'd carry it. I'll also take your other pushes. No live order until the earnings date is known, which costs nothing since there's no pullback yet. The half-size sliver at $18 to $18.50 never counts toward C. My timing rule was about entry quality, not risk control, and I should have said so. Your correlation point is the best new thing in the last round. The starter belongs inside the caller's total software exposure. If someone already holds ADBE, DOCU, MDB or MNDY at full weight, the INTU starter should be funded by trimming something else or skipped, since it's the same bet on the same AI headline.

One more thing for both of you. You each leaned on the Q4 buyback figure, one to argue a smaller share count and one to argue a bigger one. Add up operating, investing and financing cash flow for the year and you get roughly a quarter-billion outflow, while balance-sheet cash rose about $1.8B. That probably reflects restricted cash and customer funds in the reconciliation, but I can't verify it from here. It also means the $7.7B financing line may not be all repurchases. So the repurchase table in the 10-K is the number to read, not something to infer from the summary.

On the label, I'm staying at Hold. Aggressive, you said yourself that if the order text is identical, the practical gap is near zero, and I agree. Today the plan's action is nothing, the gate hasn't been run, sizing stays at market weight until the weekly turns, and nobody knows the caller's book. A Hold with the upgrade condition written into the same line costs you nothing on the path where the stock pulls back and holds.

Here's what I'd put down. Don't buy at 334.52, and don't add into 340 to 344. This week, run the gate: the FY27 guide, the repurchase table, stock comp, the Q4 net-income offset, the 10-year yield and the earnings date. Also check the caller's existing software exposure. Then size the starter by the guide. It's 25% of target if the guide supports $18.50 or better, about half that between $18 and $18.50, and nothing below $18. Place it at 316 to 320 on a daily hold. It should fill at least a week before the print or lapse, with one attempt before the print. Skip Tranche B. A close under 298.38 cancels all pre-print buying, and the business case gets re-underwritten after the print, not buried.

After the print, add a second quarter only if all of these hold: - Revenue growth is low-teens or better. - Margins hold. - The guide is near $18.50. - The price is no higher than about 17.5x that guide. - The add comes on a hold, not a chase.

Nothing goes above standard weight until the weekly closes above 390.56 or tax season shows growth back in the low teens. If you're flat, wait for the pullback. If you're at standard weight, don't add. If you're overweight, trimming into 340 to 344 is reasonable. Recheck every level after the close, since today's bar is probably partial.

So the call is Hold today, upgrading to a Buy starter when the gate clears, at 316 to 320 on a daily hold, never at market. Neutral Analyst: You've converged on the order, so what's left is a word and some mechanics. I'll take each of you in turn and then give the package.

Aggressive, you keep saying the starter keeps us in the scenario the plan expects. Run its arithmetic. A 318 fill to the stop is about 6% down, which on a quarter-size position is about 1.5% of a standard holding. From 318 to the 333-342 base-case range is 5 to 8% up, or 1.2% to 1.9% of a standard position. In the base case the starter risks about what it makes. It only gets interesting in the 360-380 tail, which needs the top of the EPS range and a multiple above the 18x we call fair. That's a reasonable small trade, but it's roughly symmetric with some right-tail skew, not an asymmetric bet.

Your own rules also shrink the ladder. Tranche C only fires at about 17.5x guided earnings, around 324, after a clean print. Nothing goes past standard weight until the weekly flips at 390 or tax season shows up. On most paths the realistic end state is a quarter-size tactical position, which is below market weight. A Buy that maps to Overweight and up to 1.25x promises more than the plan delivers. I'll grant your Hold failure mode, that someone never runs the gate. The fix is a deadline and a default, not the word Buy. Give the gate a few trading days. If it hasn't been run by then, no order goes in and the call stays Hold.

Conservative, I have three pushes. First, you've been sizing every print as May 21, and August deserves a closer look. The stock closed at 368 on the 24^th, and an officer sold near 346 on the 27^th. If that fill is representative, the reaction to the print was closer to 6% than 20%, and most of the slide to 267 was drift over the following five weeks. That doesn't make the next print safe, since May is still on the tape. But it means a quarter-size position faces a gap range of roughly 1.5% to 5%, plus drift, which the stop handles. It also shows that a stock can keep falling after a clean print for reasons outside our checklist. That is why I'll take your multi-session hold on Tranche C: five sessions above the post-print low and above the cancel level.

Second, your starter hold test. Two consecutive closes at or above 316, then a fill next session at 320 or less, will rarely fill. The zone is four points wide and ATR is 12, so a stock that touches the zone and closes above 316 twice is usually above 320 by the third session. That makes it a Hold in disguise. I'd loosen it to one close back above 316 after the touch, with a limit a couple of points above the zone, around 322. That's still evidence of a hold and still avoids catching a falling bar.

Third, you said the case for owning is a multiple that stops falling, and no document verifies that. I agree, and it supports the plan's structure. If documents can only veto, the only available evidence is price holding, which is what the starter's trigger waits for. So the gate vetoes and the hold confirms. Neither should be asked to do the other's job.

There are three things neither of you has nailed down.

August 26 is still an inference. We've all started treating it as the Q4 print and the guide as published. That's the likeliest read, but item zero is to confirm it.
The gate has to read GAAP. The thresholds are GAAP EPS, but companies like this usually guide on both bases, and the $26.94 forward figure looks non-GAAP. Someone reading the wrong line will clear the gate by accident, so write "GAAP" into the rule. The gap between the two lines also gives a ceiling on stock comp plus amortization, which is the number we keep missing for FCF.
The entry zone floats. It's anchored on the 10 EMA and 50 SMA near 319, and those move. If the stock grinds higher before pulling back, the cluster rises. Like the cancel level, fix the zone in dollars the day the order is placed and review it deliberately.

My call is Hold today, with the upgrade written into the same line: Buy a starter once the gate clears, at the fixed dollar zone on a hold, never at market. I'd stay at Hold because nothing has been verified and the realistic sizing is below market weight. I'd also rather the headline fail safe for a reader with no portfolio context.

Don't buy at 334.52 and don't add into 340-344. Over the next few trading days, run the gate in this order:

The consumer tax segment guide, since the unverified 2-3% TurboTax claim is the one fact that would change the call.
Confirm the August print and the published guide.
The GAAP guide line, the repurchase table, stock comp and the Q4 net-income offset.
The 10-year yield, since a 4.9% earnings yield means little without it.
The earnings date.
The caller's existing software exposure.

If the GAAP guide supports $18.50 or better, place a 25% starter. Between $18 and $18.50, place about half that, and it never counts toward the second tranche. Below $18, or if the core consumer franchise is guided at 2-3%, it stays Hold. The starter fills only on the hold test, at least a week before the print or it lapses, with one attempt. Skip the 298-305 tranche. A close under the dollar cancel level ends pre-print buying, and the business case gets re-underwritten after the print rather than buried.

After the print, the second quarter needs these conditions:

Revenue growth is low-teens or better.
Margins hold.
The GAAP guide is near $18.50.
The price is at or under about 17.5x that guide.
The five-session hold is met.

Nothing goes above standard weight until the weekly closes above 390.56 or tax season shows low-teens growth again.

In your own terms, if you're flat, wait for the pullback. If you're at standard weight, don't add. If you're overweight, trimming into 340-344 is reasonable. Fund any INTU starter from the software name you trust least, since it's the same AI-multiple bet as ADBE, DOCU, MDB or MNDY. And recheck every level after the close, since today's bar is probably partial.

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Hold

Executive Summary: Hold INTU today. Do not buy at the provisional $334.52 close or add into the $340-344 zone. If you are flat, wait for a pullback. If you are at standard weight, hold without adding. If you are overweight, trimming into $340-344 is reasonable. Within five trading days (by 2026-10-28), run the diligence gate. If FY27 GAAP EPS guidance supports $18.50 or better, upgrade to a 25%-of-target starter at a dollar-fixed $316-320 zone, on a daily hold and never at market, cancelled by a daily close below $298. Nothing goes above standard weight until a weekly close above $390.56 or tax-season growth returns to the low teens.

Investment Thesis: DECISION: The analysts converged on one identical order: no purchase at $334.52, Tranche B (298-305) dropped, a 25% starter at 316-320 only after the gate, and everything cancelled below about 298. What remains is the label, and the Neutral and Conservative case for Hold is stronger on the merits, not just because the views conflict. Three reasons. (1) The stock is fairly priced, not mispriced. FY26 was strong: revenue +13.9% to $21.45B, operating margin 27.4%, EPS +20.4% to $16.46, OCF $8.84B, net debt about 0.5x EBITDA. But at 20.3x trailing, and with the 12.4x forward P/E flattered by a likely non-GAAP $26.94, the honest FY27 GAAP range of $18-19 at the agreed 18x gives $324-342. The current price sits inside it. The Aggressive analyst conceded it is 'a fairly priced stock with wide tails' and dropped the 'priced as broken' framing. (2) The whole 25% bounce came from multiple expansion. Trailing EPS was about $16.44 on 9/29 and is $16.46 now, while the multiple went from 16.2x to 20.3x on the Sequence deal and sector beta. (3) The realistic sizing is below market weight. The plan is a quarter-size starter, half after a qualifying print, and nothing above standard until the weekly trend flips. That does not match Overweight or Buy. The action today is nothing, the gate has not been run, and portfolio context is unknown, so the headline should fail safe. I am overriding the Research Manager's Overweight and the trader's Buy labels while keeping their sequencing. RISKS THAT KEEP IT FROM OVERWEIGHT: Q3, about 67-68% of profit, slowed to +10.4% with about 100 bps of margin loss, and the cause is unknown. August is the warning case: the derived Q4 grew about 13.7% with operating income up about 40%, yet the stock fell from 368 to 267. A clean print is necessary but not sufficient. Technicals: the weekly SuperTrend is DOWN (390.56) and the monthly is DOWN (561.87). Only the daily is UP (298.38). The 200 SMA at 367.51 is still above the 50 SMA. The 340-344 zone has capped price twice, the daily TD-9 sell setup is complete, and the MACD histogram eased from 6.41 to 6.21. The payoff at market is about 0.9:1. Scenarios from a $318 fill: bear 15x × $18 = $270 (the June low was about 15.4x), about -15%. Base $324-342, +2% to +7%. Bull $360-380, which needs the top of the EPS range and a multiple above fair. The starter risks roughly what it earns in the base case (about 1.5% of a standard position to the stop, about 5% on a repeat 20% gap), so it is a tactical trade, not a mispricing. GATE (in order): (a) consumer-tax segment guidance, since the unverified 2-3% TurboTax claim would change the call; (b) confirm that 8/26 was the Q4 print and the guidance published with it; © the GAAP guidance line, not the non-GAAP one; (d) the 10-K repurchase table, because cash-flow components sum to about a $0.25B outflow while cash rose about $1.8B, so the $7.7B financing outflow may not be all buybacks; (e) SBC; (f) whether the roughly $100-150M Q4 net-income offset recurs; (g) the 10-year yield, since FRED failed, to judge the 4.9% earnings yield; (h) the earnings date; (i) your existing software exposure, because ADBE, DOCU, MDB and MNDY carry the same AI-multiple bet, so fund any starter from the weakest of those or skip it. SIZING: GAAP guidance of $18.50 or better means a 25% starter. Between $18 and $18.50, use about 12%, which never counts toward Tranche C. Below $18, or consumer tax at 2-3%, stays Hold with no order. STARTER MECHANICS: fix the zone and cancel level in dollars on placement. Buy after a touch of 316-320 and a daily close back above 316, with a limit of about $322. It must fill at least a week before the confirmed print or it lapses. Allow one attempt and no re-entry before the print. TRANCHE C (to 50% of target, after the print) requires all of: low-teens revenue growth, margins holding, a GAAP guide near $18.50, a price at or below about 17.5x that guide (about $324), and five sessions above both the post-print low and the cancel level. WHAT CHANGES IT: Upgrade to Overweight when the gate clears at $18.50 or better and the starter triggers. Size above standard only on a weekly close above 390.56 or Q3 FY27 low-teens growth. Move to Underweight if the GAAP guide is below $18, consumer tax is at 2-3%, the Q4 offset recurs, or Q3 FY27 growth is below about 8% or operating margin in that quarter falls below about 46%, especially with a daily close below 298 and a slide toward 261-267. PRICE TARGET: valuation objective = 18x (the multiple both sides called fair) × $18.50 (midpoint of the agreed $18-19 FY27 GAAP range) = $333. Cross-check: the $324-342 range sits around the 340-344 resistance. A target just below $334.52 is consistent with Hold. The edge exists only at the $316-320 entry, about 5% below $333. DATA CAVEATS: the 10/21 bar is likely partial (951,640 shares vs a 2.5-4.5M norm), so recheck all levels after the close. Segment splits, SBC, the financing split, the earnings date, Treasury yields and the FY27 guidance are all unread or missing, and the two FCF sources conflict ($6.35B vs $8.66B).

Current Price: 334.52

Price Target: 333.0

Confidence: Medium

Time Horizon: 6-7 months

Trading Analysis Report: INTU¶

I. Analyst Team Reports¶

Market Analyst¶

INTU (Intuit Inc., NMS): Technical Report¶

1. Data integrity notes¶

2. Big picture: a deep downtrend with a sharp counter-trend rally¶

3. Trend structure (weekly outranks monthly, which outranks daily)¶

4. Momentum: strong, but plateauing¶

5. Trend strength (ADX)¶

6. Volatility and range position¶

7. Volume (OBV)¶

8. Exhaustion and stretch¶

9. Reference levels from the data¶

10. Scenarios¶

11. Bottom line for the deciding agent¶

Summary table¶

Sentiment Analyst¶

News Analyst¶

INTU (Intuit Inc.) – News & Macro Report, week of 2026-10-14 to 2026-10-21¶

1. Data coverage and caveats¶

2. Company news: Intuit (INTU)¶

3. Macro and market backdrop¶

4. Trading implications for INTU¶

5. Summary table¶

Fundamentals Analyst¶

INTU (Intuit Inc.): Fundamental Report¶

1. Bottom line¶

2. Snapshot (from get_fundamentals)¶

3. Income statement¶

4. Cash flow and capital allocation¶

5. Balance sheet (7/31/2026 vs 7/31/2025, USD millions)¶

6. Insider activity¶

7. Risks and watch items¶

8. Data caveats¶

9. Summary table¶

II. Research Team Decision¶

Bull Researcher¶

1. The business kept compounding while the stock halved¶

2. Cash flow and capital allocation¶

3. Moat and strategy¶

4. The tape is starting to agree¶

5. Where I expect the bear to push, and my response¶

6. What would prove me wrong¶

What I concede¶

1. Your $18.1–18.4 FY27 EPS is a floor scenario, not a base case¶

2. Your FCF haircut makes my number better¶

3. The buyback ruler¶

4. AI: the P&L is the test, not the 50% drawdown¶

5. The tape and the price of certainty¶

6. Insiders and rates, briefly¶

Where this leaves the position¶

What I concede¶

1. Your own table is my case¶

2. The AI test: what disintermediation would look like¶

3. The carry, honestly¶

4. "Wait for the 10-K and the guide"¶

5. The plan, fixed¶

Verdict¶

What I concede¶

1. The grid's average is just its center¶

2. The unexplained quarter is already in your model¶

3. The print and the gap¶

4. The stop, fixed¶

5. What the remaining disagreement is worth¶

Verdict¶

What I concede¶

1. The gate, with pass/fail numbers set in advance¶

2. Why the starter still goes in after the gate¶

3. Final plan¶

Verdict¶

Bear Researcher¶

1. Q3 and AI are one story, and your "re-acceleration" is built on the wrong quarter¶

2. Your moat quote concedes my point¶

3. "Cheap" depends on the denominator¶

4. The tape doesn't agree¶

5. Macro, sentiment and insiders¶

Verdict¶

What I concede¶

1. The EPS bridge isn't the fight. The multiple is.¶

2. A lagging P&L can't clear a forward risk¶

2. Snapshot (from `get_fundamentals`)¶